●
Earnings Feed
Filings
Companies
Insiders
Pricing
Blog
⌘
K
Login
Start Free
GenuTec Business Solutions, Inc.
·
S-1
Aug 14, 5:30 PM ET
Share
GenuTec Business Solutions, Inc. S-1
Loading document...
Share
More
Contents
432
Section 1. Definitions.
Section 1.1. Defined Terms. For the purposes of this Agreement, the following terms shall have the following respective meanings:
Section 1.2. Accounting Principles.
(a) Unless the context otherwise clearly requires, all accounting terms not expressly defined herein shall be construed, and all financial computations required under this Agreement shall be made, in accordance with GAAP, consistently applied.
(b) References herein to “fiscal year”, “fiscal quarter” and “fiscal month” refer to such fiscal periods of the Company, which shall not be changed without the prior written approval of the Majority Purchasers.
(c) If at any time after the Exchange Date any change in GAAP is occasioned by promulgation of rules, regulations, pronouncements or opinions by or is otherwise required by the Financial Accounting Standards Board or the American Institute of Certified Public Accountants (or successors thereto or agencies with similar functions), and such change would affect the calculation of any financial ratio or other financial requirement set forth in this Agreement or any other Note Document, then upon the request of either the Company or the Majority Purchasers, the Company and the Majority Purchasers shall negotiate in good faith to amend such ratio or requirement so as to preserve the original intent thereof in light of such change in GAAP; provided that, until so amended, (i) such financial ratio or requirement shall continue to be computed in accordance with GAAP as in effect immediately prior to such change therein, and (ii) the Company shall provide to each of the Purchasers financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.
Section 1.3. Rules of Construction. References in this Agreement to “Articles”, “Sections”, “Annexes”, “Exhibits” or “Schedules” shall be to Articles, Sections, Annexes, Exhibits or Schedules of or to this Agreement unless otherwise specifically provided. Singular words shall connote the plural as well as the singular, and vice versa (except as otherwise indicated), as may be appropriate. “Include”, “includes” and “including” shall be deemed to be followed by “without limitation”. Except as otherwise specified herein, references to any Person include the successors and assigns of such Person. Unless otherwise specified, references “from” any date mean “from and including,” and references “to” any date mean “to but not including.” References to any statute or act shall include all related current regulations and all amendments and any successor statutes, acts and regulations. The words “herein”, “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular section or subsection. Reference herein to any section or subsection refers to such section or subsection (as the case may be) of this Agreement. Each covenant or agreement contained in this Agreement shall be construed (absent express provision to the contrary) as being independent of each other covenant or agreement contained herein, so that compliance with any one covenant or agreement shall not (absent such an express contrary provision) be deemed to excuse compliance with any other covenant or agreement. Where any provision of this Agreement refers to action to be taken by any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action is taken directly or indirectly by such Person. References herein
29
to the “knowledge” of any Person that is not an individual shall be deemed to refer to knowledge by a Responsible Officer of such Person.
Section 2. Issuance and Sale of Notes.
Section 2.1. Authorization of Notes.
(a) The Notes. The Company has duly authorized the issuance and sale of its Senior Secured Notes Due 2010 (collectively called the “Notes” and each individually a “Note”) in the maximum aggregate principal amount of $20,000,000 (net of repurchases). Each Note shall be substantially in the form of Exhibit A, shall be duly executed by the Company and shall be dated the date of issue thereof.
(b) Interest. Each Note shall bear interest from its date of issue on the unpaid principal amount thereof at a rate per annum equal, during any Interest Rate Period, to the Applicable Interest Rate for such Interest Rate Period, payable in cash (i) quarterly in arrears on the last Business Day of February, May, August and November in each year (commencing with the first such date occurring after the date of issue thereof), (ii) upon each optional or mandatory prepayment of any or all of the principal amount thereof (with respect to the principal amount so prepaid), and (iii) at maturity (whether at stated maturity, or by acceleration or otherwise).
(c) Post-Default Interest. Notwithstanding the provisions of subsection (b) of this Section 2.1, upon the occurrence and during the continuance of an Event of Default, the Notes shall bear interest at a rate per annum equal to the Post-Default Rate on the unpaid principal amount thereof and, to the extent permitted by applicable law, on any overdue interest, until the same shall be paid, such interest to be payable in cash on demand.
(d) Computation of Interest. Interest on the Notes shall be calculated on the basis of a year of 360 days, in each case for the actual number of days occurring in the period for which such interest is payable.
Section 2.2. Sale and Purchase of Notes.
(a) Right to Exchange Preferred Shares for Notes. The holders of the outstanding Preferred Shares shall have an option (the “Exchange Option”) exercisable at any time on one occasion, to exchange any or all of the outstanding Preferred Shares owned by them for Notes, at the rate of $1,000 principal amount of Notes for each Preferred Share. The Exchange Option may be exercised upon written notice thereof given to the Company by the holders of a majority of the Preferred Shares at the time outstanding (the “Majority Holders”), stating the date on which such exchange of Preferred Shares for Notes shall occur (the “Exchange Date”), which date shall be not less than two (2) Business Days nor more than ten (10) Business Days after the date of such notice. The Majority Holders shall simultaneously give written notice of the exercise of the Exchange Option to all other holders of Preferred Shares. Notwithstanding the foregoing, the Exchange Option may be exercised in any event by any holder of outstanding Preferred Shares upon written notice to the Company and the other holders of Preferred Shares at any time after the earlier of (i) ten (10) Business Days after the date on which TICC shall receive a license
30
from the California Department of Corporations pursuant to the California Finance Lenders Law and (ii) May 3, 2006.
(b) Exchange of Notes for Shares. The sale and delivery of the Notes to be issued hereunder in exchange for Preferred Shares shall take place at the offices of Nixon Peabody LLP, 437 Madison Avenue, New York, New York 10022 at 10:00 a.m., New York time on the Exchange Date. On the Exchange Date, each Purchaser desiring to exchange Preferred Shares for Notes shall deliver to the Company at its address for notice set forth in Section 16.5 hereof stock certificates representing the Preferred Shares then being exchanged by it hereunder, accompanied by appropriate stock powers executed by such Purchaser in blank, and the Company shall execute and deliver to such Purchaser Notes in the name of such Purchaser or its nominee and dated the Exchange Date in an aggregate principal amount equal to the product of $1,000 multiplied by the number of Preferred Shares being exchanged by such Purchaser. Such Notes shall be deemed to be issued and outstanding as of the Exchange Date. The Preferred Shares exchanged hereunder shall be deemed cancelled and retired as of such Exchange Date and shall not be thereafter reissued. Prior to the Exchange Date, such Notes shall not be deemed to be issued or outstanding or to represent Indebtedness or obligations of the Company or its Subsidiaries.
(c) Payment of Remaining Accumulated Dividends. Not later than 2:00 p.m. (New York City time) on the Exchange Date, the Company shall pay to each Purchaser exchanging Preferred Shares for Notes on such date in immediately available funds the amount of all unpaid dividends accrued on such Preferred Shares to but not including the Exchange Date (whether or not earned or declared).
(d) Issuance of Notes and Initial Warrants to Seaview in Certain Cases. In the event that the Exchange Date shall be earlier than 60 days after the Closing Date and, as of the Exchange Date, Seaview shall not have purchased any Preferred Shares pursuant to the provisions of the Stock Purchase Agreement, then, on the Exchange Date or such later date as Seaview shall determine (provided that such date shall in no event be more than 60 days after the Closing Date), and subject to (x) the receipt by Seaview on or prior to such date of all necessary approvals of the United States Small Business Administration (the “SBA”) required in connection with Seaview’s investment in the Notes and Warrants contemplated hereby, (y) the satisfaction or written waiver by Seaview of all of the conditions set forth in Section 6.2 of the Stock Purchase Agreement (other than 6.2(c)(i) and (ii), 6.2(f) and 6.2(k)), and (z) the absence of any Event of Default (unless such condition is waived in writing by Seaview), the Company agrees to issue and sell to Seaview, and Seaview agrees to purchase, (i) Notes, dated such date of issuance to Seaview, in an aggregate principal amount equal to $5,000,000, and (ii) Warrants (the “Seaview Initial Warrants”) initially exercisable to purchase an aggregate number of shares of Company Common Stock equal to 25% of the aggregate number of such shares for which the TICC Initial Warrants are then exercisable (after giving effect to any adjustments thereto that may have been required during the period since the Initial Closing Date), at the same exercise price per share that is then applicable to the TICC Initial Warrants (after giving effect to any such adjustments), all for an aggregate purchase price of $5,000,000. Upon such issuance and sale, (A) the Company shall pay to Seaview a closing fee of $100,000, and (B) the Company shall repurchase from TICC, and TICC shall sell to the Company, Notes held by it in an aggregate
31
principal amount of $5,000,000 and TICC Initial Warrants exercisable to purchase an aggregate number of shares of Company Common Stock equal to the aggregate number thereof for which the Seaview Initial Warrants are initially exercisable, for a purchase price payable by the Company to TICC in immediately available funds equal to the sum of $5,000,000 plus all unpaid interest accrued on such repurchased Notes from the Exchange Date to the date of such repurchase. In the event that (AA) the Exchange Date shall be earlier than 60 days after the Closing Date and as of the Exchange Date Seaview shall not have purchased Preferred Shares pursuant to the Stock Purchase Agreement, and (BB) Seaview shall not have purchased Notes pursuant to this Section 2.2(d) within 60 days after the Closing Date, then Seaview shall have no further right to purchase Notes hereunder. In such event the Company on the 61st day following the Closing Date (or, if such day is not a Business Day, on the next succeeding Business Day) shall pay to TICC an additional closing fee of $100,000.
Section 3. Payment and Prepayment of Notes. The provisions of this Section 3 shall be applicable upon and after the Exchange Date.
Section 3.1. Mandatory Payment of Principal.
(a) The principal amount of the Notes shall be paid in full on the Maturity Date, together with all unpaid accrued interest thereon.
(b) Upon receipt by the Company or its Subsidiaries of any Net Cash Proceeds resulting from:
(i) any Initial Public Offering or other public or private offering, issuance and sale of Equity Interests of the Company, other than Net Cash Proceeds received in connection with (A) a Qualified Equity Financing completed on or prior to June 16, 2006, (B) issuances of Equity Interests of the Company as full or partial consideration for or to finance a Permitted Acquisition, and (C) any issuance relating solely to employee benefit plans or solely to a transaction described in Rule 145(a) of the SEC),
(ii) the issuance and sale of debt securities of the Company or any of its Subsidiaries or of any other incurrence of Indebtedness by the Company and its Subsidiaries (other than the issuance and sale of the Notes and the incurrence of Indebtedness pursuant to this Agreement),
(iii) a Sale of the Company, or any other sale or other Disposition of assets or property of the Company or its Subsidiaries, other than in the ordinary course of business, or
(iv) subject to the provisions of the last sentence of this subsection (b), the receipt of payment due from any policy of property or casualty insurance in respect of any loss or damage to Collateral or other assets or property of the Company or its Subsidiaries covered by such policy,
Section 3.2. Optional Prepayment of the Notes. Upon notice given as provided in Section 3.3, the Company, at its option, may prepay at any time all or from time to time any part (in an aggregate amount of $100,000 or any greater amount which is an even multiple of $100,000, or any lesser amount that shall constitute the remaining principal balance of the Notes) of the principal amount of the Notes, together with accrued but unpaid interest on the principal amount being prepaid to the date of such prepayment and, with respect to any prepayment made pursuant to this Section 3.2 on or prior to the first anniversary of the Closing Date, a prepayment charge equal to 5.0% of the principal amount being prepaid. Each prepayment made pursuant to this Section 3.2 shall be allocated and applied as provided in Section 3.4; provided that no such prepayment charge shall be payable in the event that such prepayment is made out of the Net Cash Proceeds of a substantially concurrent Sale of the Company or Qualified Equity Financing.
Section 3.3. Notice of Prepayment of the Notes. The Company shall call Notes for prepayment pursuant to Section 3.2 by giving written notice thereof to each of the Purchasers not less than 30 nor more than 60 days prior to the date fixed for such prepayment. Such notice shall specify (a) the date fixed for such prepayment, (b) the principal amount to be prepaid on such date, and (c) the amount of accrued interest to be paid on such date. Notice of prepayment having been so given, the aggregate principal amount of the Notes so to be prepaid as specified in such notice, together with interest accrued thereon to such date fixed for prepayment, plus the applicable prepayment charge, if any, shall become due and payable on the specified prepayment date.
Section 3.4. Manner, Time and Allocation of Payments.
(a) Each amount payable hereunder or under the Notes shall be paid in Dollars, by wire transfer or other immediately available funds, without deduction, set-off or counterclaim, to the Purchasers at such accounts and banks as shall be designated by the respective Purchasers from time to time by written notice to the Company, not later than 2:00 p.m. (New York City time) on the day on which such amount is due hereunder. Any amount received later than 2:00 p.m. (New York City time) on any day shall be deemed received on the next succeeding Business Day.
(b) Payments made to the Purchasers hereunder shall be applied first to the payment of fees, costs, expenses and indemnities and other amounts due hereunder (other than principal, interest and prepayment charges), second to the payment of accrued interest, and third to the payment of the principal amount of the outstanding Notes and prepayment charges (if any). Payments and prepayments of principal and interest on the Notes shall be allocated to the
33
outstanding Notes pro rata in accordance with the respective principal amounts thereof then outstanding. Principal amounts of the Notes that are paid or prepaid hereunder may not be reborrowed.
Section 3.5. Payments Free and Clear of Taxes.
(a) Any and all payments under this Agreement and the Notes shall be made free and clear of, and without deduction or withholding for, any and all present or future federal, state, local and foreign taxes, levies, imposts, deductions, charges or withholdings, and all liabilities with respect thereto, excluding such taxes as are imposed on or measured by each of the Purchasers’ net income by the jurisdiction under the laws of which such Purchaser is organized or conducts business or any political subdivision thereof (“Taxes”). If the Company shall be required by law to deduct any Taxes from or in respect of any sum payable hereunder or under the Notes, (i) the sum payable shall be increased as much as shall be necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section 3.5(a)) the applicable Purchaser shall receive an amount equal to the sum it would have received had no such deductions been made, (ii) the Company shall make such deductions, and (iii) the Company shall pay the full amount deducted to the relevant taxing or other authority in accordance with applicable law.
(b) In addition, the Company agrees to pay any present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies that arise from any payment made under this Agreement or the Notes or from the execution, delivery or registration of, or otherwise with respect to, this Agreement (hereinafter referred to as “Other Taxes”).
(c) The Company will indemnify the each of the Purchasers for the full amount of Taxes or Other Taxes imposed by any jurisdiction and paid by such Purchaser, and any liability (including penalties, interest and expenses) arising therefrom or with respect thereto, whether or not such Taxes or Other Taxes were correctly or legally asserted. Such indemnification payment shall be made within 30 days after the date such Purchaser makes written demand therefor.
(d) Within 30 days after the date of any payment of Taxes or Other Taxes, the Company will furnish to the Purchasers the original or a certified copy of a receipt evidencing payment thereof.
(e) Without prejudice to the survival of any other agreement contained herein, the agreements and Obligations contained in this Section 3.5 shall survive the payment in full of principal, interest, fees and any other amounts payable hereunder (other than amounts payable pursuant to this Section 3.5).
Section 3.6. Payments Due on Days Not Business Days. Whenever any payment hereunder or under the Notes shall be stated to be due on a day other than a Business Day, that payment shall be made on the next preceding Business Day.
34
Section 3.7. Surrender of Notes; Notation Thereon. The Company may, as a condition of payment of all or any part of the principal of, prepayment charge (if any) and interest on, any Note, require the holder of such Note to present such Note for notation of such payment and, if such Note is to be paid in full, require the surrender thereof.
Section 4. Representations and Warranties of the Company. The Company represents and warrants to the Purchasers that, as of the Closing Date after giving effect to the Acquisition Transactions and the transactions contemplated by the Stock Purchase Agreement:
Section 4.1. Corporate Existence and Power. Each of the Company and its Subsidiaries (a) is a corporation or (as the case may be) a limited liability company duly organized, validly existing and in good standing under the laws of its respective jurisdiction of incorporation or organization, (b) is duly qualified to do business in each additional jurisdiction where the failure to so qualify would have a Material Adverse Effect, and (c) has all requisite power (corporate or limited liability company, and other) to own its respective properties and to carry on its respective businesses as now being conducted and as proposed to be conducted, and to execute, deliver and perform its Obligations under the Note Documents to which it is respectively a party.
Section 4.2. Corporate Authority. The execution, delivery and performance by the Company of this Agreement and the other Note Documents to which the Company is a party have been duly authorized by all necessary corporate action on the part of the board of directors and stockholders of the Company. The execution, delivery and performance by each Subsidiary of the Company of the Note Documents to which such Subsidiary is a party have been duly authorized by all necessary corporate or (as the case may be) limited liability company action on the part of such Subsidiary.
Section 4.3. Binding Effect. This Agreement and each of the other Note Documents to which the Company is a party have been duly executed and delivered by the Company and are (or, in the case of the Notes, will be when issued) the legal, valid and binding obligations of the Company, in each case enforceable against the Company in accordance with their respective terms, except to the extent that such enforcement may be limited by applicable bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and by general principles of equity. Each of the Note Documents to which any Subsidiary of the Company is a party has been duly executed and delivered by such Subsidiary and are the legal, valid and binding obligation of such Subsidiary, enforceable against such Subsidiary in accordance with its terms, except to the extent that such enforcement may be limited by applicable bankruptcy, insolvency and other similar laws affecting creditors’ rights generally and by general principles of equity.
Section 4.4. Liens and Security Interests. On the Exchange Date, the Liens and security interests created pursuant to the Security Documents will constitute legal, valid and perfected first priority Liens and security interests in all of the Collateral purported to be covered thereby, subject to no other Liens except Permitted Liens.
Section 4.5. No Conflicts with Agreements, Etc. Neither the execution and delivery by the Company of this Agreement or any of the other Note Documents to which it is a party, nor
35
the execution and delivery by any Subsidiary of the Company of any of the Note Documents to which it is a party, nor the offering, issuance or sale of the Notes nor the fulfillment of or compliance with the terms and provisions hereof or thereof, will conflict with, or result in a breach or violation of the terms, conditions or provisions of, or constitute a default under, or result in the creation of any Lien (other than Liens created pursuant to the Security Documents) on any properties or assets of the Company or its Subsidiaries pursuant to, the Organizational Documents of the Company or any of its Subsidiaries, or any contract, agreement, mortgage, indenture, lease or instrument to which any of them is a party or by which any of them is bound or to which any of them or any of their respective assets are subject, or any Requirement of Law to which any of them or any of their respective assets are subject.
Section 4.6. Consents, Etc. No consent, approval or authorization of or declaration, registration or filing with any Governmental Authority or any nongovernmental Person, including any creditor or stockholder of the Company or any of its Subsidiaries, is required in connection with the execution or delivery by the Company of this Agreement or the other Note Documents to which the Company is a party, or in connection with the execution or delivery by any Subsidiary of the Company of the Note Documents to which it is respectively a party, or the performance by the Company or such Subsidiary of its Obligations hereunder and thereunder, or as a condition to the legality, validity or enforceability of this Agreement or any other Note Document, except for filing of financing statements required in order to perfect the Liens of the Collateral Agent in the Collateral or to exercise remedies thereunder, and except for such consents, approvals, authorizations, declarations, registrations or filings as are listed in Schedule 4.6, all of which have been or will on or prior to the Closing Date be obtained and are or will then be in full force and effect.
Section 4.7. Equity Interests.
(a) The authorized Equity Interests of the Company consist of 100,000,000 shares of Company Common Stock and 10,000,000 shares of Company Preferred Stock, including 25,000 shares of Series A Preferred Stock. Set forth in Schedule 4.7 is a true and complete list of the holders of five percent (5%) or more of the outstanding shares of Company Common Stock and of all of the Company Preferred Stock, and of all outstanding Options, Convertible Securities and other Call Securities (each as defined below), together with the number of such shares of each class, or amount of Options, Convertible Securities or other Call Securities, held by each such holder. All of the issued and outstanding shares of Company Common Stock and Company Preferred Stock are validly issued, fully paid and non-assessable. Except as set forth in Schedule 4.7 and except for the Warrants, there are no outstanding (i) options, warrants or rights to subscribe for or purchase, or agreements (contingent or otherwise) providing for the issuance of, or calls, commitments or claims of any character relating to, any shares of Company Common Stock or Company Preferred Stock (“Options”), (ii) securities (including debt securities and equity securities) that are or by their terms may become convertible into or exchangeable for any shares of Company Common Stock or Company Preferred Stock (“Convertible Securities”), or (iii) options, warrants or rights to subscribe for or purchase, or agreements (contingent or otherwise) providing for the issuance of, or calls, commitments or claims of any character relating to, any Convertible Securities (together with Options and Convertible Securities, “Call Securities”). Except as set forth in Schedule 4.7, none of the authorized Equity Interests of the
36
Company constitutes Redeemable Stock, and the Company has no obligation, whether mandatory or at the option of any other Person, at any time to redeem or repurchase any shares of Company Common Stock or Company Preferred Stock or any Call Securities, pursuant to the terms of the Company’s Organizational Documents or by contract or otherwise.
(b) The shares of Company Common Stock issuable upon exercise of the Warrants have been duly and validly reserved for issuance upon such exercise and, when issued and delivered against payment therefor as provided therein, will be duly authorized, validly issued, fully paid and non-assessable and subject to no Liens in respect of the issuance thereof.
Section 4.8. Existing Financial Statements; Projections; No Material Change.
(a) The Company has delivered to the Purchasers true and complete copies of (i) the audited consolidated balance sheets of the Company and its Subsidiaries as of September 30, 2003 and 2004, and the related audited consolidated statements of income, retained earnings and cash flows for each of the fiscal years then ended, together with the notes thereto and the reports thereon of the Accountants (the “Audited Financial Statements”), (ii) the unaudited consolidated balance sheets of the Company and its Subsidiaries as of June 30, 2005, and the related unaudited consolidated statements of income, retained earnings and cash flows for the nine-month then ended (the “Interim Financial Statements”), and (iii) the unaudited combined balance sheets of SDI and its Affiliate SBN Peripherals, Inc. (“SBN”) as of October 31, 2003 and 2004 and as at June 30, 2005 and the related unaudited combined statements of income of SDI and SBN for each of the two fiscal years ended October 31, 2004 and the twelve months ended June 30, 2005 (collectively, the “SDI Group Financials”; the Audited Financial Statements, the Interim Financial Statements and the SDI Group Financials are sometimes hereinafter collectively referred to as the “Existing Financial Statements”). The Existing Financial Statements have been prepared in accordance with GAAP (except as noted thereon) consistently applied throughout the periods involved, and present fairly, in all material respects, the consolidated financial position and related consolidated income, retained earnings and cash flows of the Company and its Subsidiaries and the combined financial position and income of SDI and SBN (the “SDI Group”) as at each of the dates and for each of the periods covered thereby, subject, in the case of the Interim Financial Statements and the SDI Group Financials, to non-material year-end audit adjustments and absence of the notes required by GAAP.
(b) As of the date of each of the balance sheets included in the Existing Financial Statements, neither the Company nor any of its Subsidiaries, nor the SDI Group had any Indebtedness or liability, absolute or contingent, liquidated or unliquidated, except Indebtedness and liabilities reflected or reserved against on such respective balance sheets or described in the notes thereto.
(c) The Projections, a true and complete copy of which is attached hereto as Schedule 4.8(c), are reasonable in light of the historical operations and results of the Predecessor Company, represent management’s good faith best estimate of the future operating performance of the Company and its Subsidiaries and were prepared on an accounting basis consistent with the Audited Financial Statements. The Projections reflect all adjustments recommended by the Accountants.
37
(d) The pro forma balance sheet of the Company as of June 30, 2005, a copy of which is attached hereto as Schedule 4.8(d), presents fairly in all material respects, in conformity with GAAP applied on a basis consistent with the Audited Financial Statements, the consolidated financial position of the Company as of such date, as adjusted to give effect (as if such events had occurred on such date) to (i) the Acquisition Transactions, (ii) the transactions contemplated by the Stock Purchase Agreement, and (iii) the payment of all legal, accounting and other fees and expenses related thereto to the extent known at the time of the preparation of such balance sheet.
(e) Except as set forth in Schedule 4.8(e), there has not been, since September 30, 2004:
(i) any change in the business, financial condition, properties, operations or prospects of the Company and its Subsidiaries from that reflected in the Audited Financial Statements, other than changes in the ordinary course of business, none of which individually or in the aggregate has had or is expected to have a Material Adverse Effect;
(ii) any resignation or termination of any officers or key employees of the Company or any of its Subsidiaries, and the Company and its Subsidiaries have no knowledge of any impending resignation or termination of employment of any such officer or key employee;
(iii) any material change, except in the ordinary course of business, in the contingent obligations of the Company or any of its Subsidiaries by way of guaranty, endorsement, indemnity, warranty or otherwise;
(iv) any damage, destruction or loss, whether or not covered by insurance, which has had a Material Adverse Effect;
(v) any waiver by the Company or any of its Subsidiaries of a valuable right or of a material debt owed to it;
(vi) any direct or indirect loans made by the Company or any of its Subsidiaries to any stockholder, employee, officer or director of the Company or any of its Subsidiaries, other than advances made in the ordinary course of business;
(vii) any material change in any compensation arrangement or agreement with any employee, officer or director of the Company or any of its Subsidiaries;
(viii) any declaration or payment of any dividend or other distribution of the assets of the Company or any of its Subsidiaries;
(ix) to the knowledge of the Company and its Subsidiaries, any labor organization activity with respect to any employees of the Company or any of its Subsidiaries;
38
(x) any debt, obligation or liability incurred, assumed or guaranteed by the Company or any of its Subsidiaries, except those for immaterial amounts and for current liabilities incurred in the ordinary course of business;
(xi) any sale, assignment or transfer of any Patents, Trademarks, Copyrights, trade secrets or other Intellectual Property by the Company or any of its Subsidiaries;
(xii) any change in any Material Contract that could reasonably be expected to have a Material Adverse Effect;
(xiii) any satisfaction or discharge of any Lien or payment of any obligation by the Company or any of its Subsidiaries, except in the ordinary course of business and that is not material to the business, properties, financial condition, operations or prospects of the Company or any of its Subsidiaries;
(xiv) any Lien on any asset of the Company or any of its Subsidiaries except Permitted Liens;
(xv) any action, suit, proceeding or investigation against the Company or any of its Subsidiaries, except any such action, suit, proceeding or investigation that (A) is not material to the business, properties, financial condition, operations or prospects of the Company or any of its Subsidiaries or (B) is set forth on Schedule 4.8(d);
(xvi) any written communication received by the Company or any of its Subsidiaries alleging that the Company or any of its Subsidiaries or any of its products or services has violated any of the Patents or Patent Licenses and other proprietary rights and processes of any other Person; or
(xvii) any other events or conditions of any character that, either individually or in the aggregate, have resulted or could reasonably be expected to result in a Material Adverse Effect.
Section 4.9. Subsidiaries. Set forth in Schedule 4.9 attached hereto is a true and complete list of all direct and indirect Subsidiaries of the Company, setting forth as to each such Subsidiary its jurisdiction of incorporation or organization and the percentage of each class of Equity Interests of such Subsidiary owned by the Company or a Subsidiary of the Company. Neither the Company nor any Subsidiary of the Company owns any Equity Interests of any Person other than the Subsidiaries listed in Schedule 4.9. The Company and its Subsidiaries have good title to all of the Equity Interests owned by them of each of the Company’s direct and indirect Subsidiaries, free and clear in each case of any Lien other than Permitted Liens. All of the Equity Interests of each Subsidiary have been duly and validly issued, and are fully paid and non-assessable and owned of record or beneficially by the Company and/or one or more of its Subsidiaries. There are no securities outstanding that are convertible into or exchangeable for any Equity Interests of the Company’s Subsidiaries, nor are there outstanding any rights to subscribe for or purchase, or any options or warrants for the purchase of, or any agreements (contingent or otherwise) providing for the issuance of, or any calls, commitments or claims of
39
any character relating to, any Equity Interests of the Company’s Subsidiaries or any securities convertible into or exchangeable for any such Equity Interests.
Section 4.10. Litigation.
(a) Except as set forth on Schedule 4.10, there are no actions, suits or proceedings pending, or, to the Company’s knowledge, threatened against or affecting the Company or any of its Subsidiaries or any properties or rights of any of them which, if adversely determined, individually or in the aggregate would have a Material Adverse Effect.
(b) There are no actions, suits or proceedings pending, or, to the Company’s knowledge, threatened against or affecting the Company or any of its Subsidiaries which seek to enjoin, or otherwise prevent the consummation of, the transactions contemplated herein or to recover any damages or obtain any relief as a result of any of the transactions contemplated herein in any court or before any arbitrator of any kind or before or by any Governmental Authority.
Section 4.11. No Violation of Law; No Default.
(a) None of the Company or its Subsidiaries is now, or will be after or as a result of giving effect to the transactions contemplated herein, in default under or in violation of any Order of any court, arbitrator or Governmental Authority or of any federal, state, local or foreign Requirement of Law, which default or violation could reasonably be expected to have a Material Adverse Effect. In particular, without limiting the generality of the foregoing, the Company and its Subsidiaries are in compliance in all material respects with the provisions of the Telemarketing Sales Rule of the Federal Trade Commission, 16 U.S.C. Part 310, including the “Do-Not-Call” provisions thereof, the regulations of the Federal Communications Commission with respect to Restrictions on Telemarketing and Telephone Solicitation, 47 C.F.R. Section 64.1200(a) — (f), including the “Do-Not-Call” provisions thereof, and similar state laws and regulations.
(b) Neither the Company nor any of its Subsidiaries is in default under or with respect to any provision of any security issued by any such Person, of any of their respective Organizational Documents, or of any agreement, undertaking, contract, indenture, mortgage, deed of trust or other instrument, document or agreement to which any such Person is a party or by which it or any of its property is bound which, individually or together with all such defaults, could reasonably be expected to have a Material Adverse Effect or that would, if such default had occurred after the Exchange Date, create an Event of Default under Section 12.1(e).
(c) No Default or Event of Default will exist on the Exchange Date immediately after giving effect to the execution and delivery by the Company and its Subsidiaries of this Agreement and the other Note Documents and the incurrence by them of their respective Obligations hereunder and thereunder, including the grant or perfection of any Lien on the Collateral granted pursuant to the Security Documents.
40
Section 4.12. Title to Properties. The Company and its Subsidiaries own no real property. Schedule 4.12 sets forth a true and complete list of all leases of real property to which any of such Persons is a party, identifying the parties to each such lease and the property to which it relates. True and complete copies of all such leases, together with all amendments, modifications and supplements thereto to the date hereof, have been delivered to the Purchasers. Each of the Company and its Subsidiaries has valid leasehold interests in all real property leased by it, and valid title to all owned personal property and valid leasehold interests in all leased personal property, in each case, necessary or used in the ordinary conduct of their respective businesses, subject to no Liens other than Permitted Liens.
Section 4.13. Taxes. The Company and its Subsidiaries have filed all federal and other material tax returns and reports required to be filed, and have paid all federal and other material taxes, assessments, fees and other governmental charges levied or imposed upon them or their properties, income or assets otherwise due and payable, except those which are being contested in good faith by appropriate proceedings diligently prosecuted and for which adequate reserves have been provided in accordance with GAAP, and no notice of Lien has been filed or recorded in respect of any such taxes. There is no proposed tax assessment against the Company or any of its Subsidiaries which would, if the assessment were made, either individually or in the aggregate, have a Material Adverse Effect.
Section 4.14. Labor Matters.
(a) Except as set forth in Schedule 4.14, (i) no strikes, work stoppages, slowdowns or other labor disputes or grievances against the Company or any of its Subsidiaries are pending or, to the Company’s knowledge, threatened, which individually or in the aggregate could reasonably be expected to have a Material Adverse Effect, (ii) none of the Company or any of its Subsidiaries is a party to any collective bargaining agreement and none of them has any knowledge of any pending or threatened effort to organize any of their employees, (iii) there are no representation proceedings pending or, to the Company’s knowledge, threatened before the National Labor Relations Board, and no labor organization or group of employees of the Company or any of its Subsidiaries has made a pending demand for recognition, (iv) neither the Company nor any of its Subsidiaries is engaged in any unfair labor practice or discriminatory employment practice and no complaint of any such practice against the Company or any of its Subsidiaries has been filed or, to the best knowledge of the Company and its Subsidiaries, threatened to be filed with or by the National Labor Relations Board, the Equal Employment Opportunity Commission or any other administrative agency, federal or state, that regulates labor or employment practices, nor has any grievance been filed or, to the best knowledge of the Company and its Subsidiaries, threatened to be filed, against the Company or any of its Subsidiaries by any employee pursuant to any collective bargaining or other employment agreement to which the Company or any such Subsidiary is a party or is bound, and (v) the Company and its Subsidiaries are in compliance with the Fair Labor Standards Act and all other applicable federal, state, local and foreign Requirements of Law relating to the employment of labor, except such non-compliance as individually and in the aggregate could not reasonably be expected to have a Material Adverse Effect.
41
(b) Schedule 4.14 sets forth a true and complete list of all employees representing executive management of the Company and its Subsidiaries and all independent contractors or consultants hired or engaged by the Company or any of its Subsidiaries. Except as set forth on Schedule 4.14, the employment of all Persons and officers employed by the Company and each of its Subsidiaries in connection with the preceding sentence is terminable at will without any penalty or severance obligation of any kind on the part of the employer. Except as set forth on Schedule 4.14, all sums due for employee compensation and benefits and all vacation time owing to any employees of any of the Company and its Subsidiaries have been duly and adequately accrued on the accounting records of the Company and its Subsidiaries.
(c) None of the Company or its Subsidiaries has knowledge that any of its employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would interfere with the use of such employee’s best efforts to promote the interests of the Company and its Subsidiaries or that would conflict with the Company’s or its Subsidiaries’ business as proposed to be conducted.
Section 4.15. Environmental Matters. Except as set forth in Schedule 4.15:
(a) The Company and its Subsidiaries, and their respective operations and properties, are in compliance in all material respects with all applicable Environmental Laws, except such non-compliance which would not (if enforced in accordance with applicable law) reasonably be expected to result in, either individually or in the aggregate, a Material Adverse Effect.
(b) The Company and each of its Subsidiaries have obtained all licenses, permits, authorizations and registrations required under any applicable Environmental Law and necessary for their respective operations (“Environmental Permits”), all such Environmental Permits are in good standing and in full force and effect, and the Company and each of its Subsidiaries are in compliance with all material terms and conditions of such Environmental Permits, except where the failure to obtain, to maintain in good standing and in full force and effect, or to be in compliance with such Environmental Permits could not reasonably be expected to result in, either individually or in the aggregate, a Material Adverse Effect.
(c) None of the Company, any of its Subsidiaries or any of their respective present properties or operations is subject to any outstanding written order from or agreement with any Governmental Authority, nor subject to any judicial or docketed administrative proceeding, with respect to any Environmental Law, Environmental Matter or Hazardous Material which could reasonably be expected to result in, either individually or in the aggregate, a Material Adverse Effect.
(d) There are no Hazardous Materials or other conditions or circumstances existing with respect to any property of the Company or its Subsidiaries, or arising from operations of the Company or its Subsidiaries prior to the Closing Date, that could reasonably be expected to result, either individually or in the aggregate, in a Material Adverse Effect.
42
Section 4.16. Compliance with ERISA.
(a) Neither the Company nor any ERISA Affiliate has established or maintains any Pension Plan or Multiemployer Plan, and no event or fact exists which could give rise to any liability to the Company or any ERISA Affiliate under Title IV of ERISA, Section 302 of ERISA or Section 412 of the Code. Schedule 4.16 lists (i) all ERISA Affiliates and (ii) all Plans, including all Welfare Plans, Retiree Welfare Plans and ESOPs and all bonus, commission, profit-sharing, saving, stock option, stock purchase, stock bonus, stock appreciation right, insurance, deferred compensation, or other employee benefit plans or arrangements, maintained or contributed to by the Company or any ERISA Affiliate to its employees or under which the Company or any ERISA Affiliate has any obligation or liability. Copies of all such listed Plans have been delivered to the Purchasers.
(b) The Company and each of the ERISA Affiliates is in compliance in all material respects with all requirements of each Plan maintained or contributed to by it or under which it has any obligation or liability, and each Plan complies in all material respects, and is operated in compliance in all material respects, with all applicable provisions of ERISA and the Code, including the timely filing of all reports required under the Code or ERISA, including the statement required by 29 CFR Section 2520.104-23. Except with respect to Multiemployer Plans, each Pension Plan that is intended to be tax-qualified under Section 401(a) of the Code has been determined by the IRS to qualify thereunder, the trusts created thereunder have been determined to be exempt from tax under the provisions of Section 501 of the Code, and nothing has occurred that would cause the loss of such qualification or tax-exempt status. Except for claims for benefits made in the ordinary course of business of the Company and its Subsidiaries, no material proceeding, claim, lawsuit and/or investigation is pending concerning any Plan. All required contributions have been made in accordance with the provisions of each Pension Plan and Multiemployer Plan, and with respect to the Company or any ERISA Affiliate, there are no material Unfunded Pension Liabilities or Withdrawal Liabilities.
(c) No ERISA Event has occurred or is expected to occur with respect to any Pension Plan, Multiemployer Plan or other Plan which could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect.
(d) The Company and the ERISA Affiliates currently comply and have complied in all material respects with the notice and continuation coverage requirements of Section 4980B of the Code.
Section 4.17. Material Contracts. Schedule 4.17 contains a list of all Material Contracts to which the Company or any of its Subsidiaries is a party (other than leases listed on Schedule 4.12 and Licenses listed on Schedule 4.20(c)). True and complete copies of each of the Material Contracts, with all amendments, modifications and supplements thereto to the date hereof, have previously been furnished by the Company to the Purchasers or their representatives. Each of such Material Contracts is valid, subsisting and in full force and effect. None of the Company and its Subsidiaries is in breach or violation of any of the terms, conditions or provisions of any of such Material Contracts, and to the best knowledge of the Company no third party to any of the Material Contracts is in breach or violation of any of the terms, conditions or provisions
43
thereof. Neither the Company nor any of its Subsidiaries has transferred or subordinated any of its rights or interests in any of the Material Contracts, and such rights and interests are subject to no Liens except Permitted Liens. Neither the Company nor any of its Subsidiaries is a party to any Material Contract or is subject to any restriction contained in the charter or by-laws of any of them which individually or in the aggregate has had or is reasonably likely to have a Material Adverse Effect.
Section 4.18. Insurance. The Company and its Subsidiaries and their respective properties are insured with insurance companies reasonably believed by the Company to be financially sound and reputable, and which are not Affiliates of the Company, in such amounts, with such deductibles and covering such risks as are customarily carried by companies engaged in similar businesses and owning similar properties in localities where the Company or such Subsidiary operates. A true and complete listing of such insurance, including issuers, coverages and deductibles is set forth in Schedule 4.18. All premiums in respect of such policies have been paid through the Closing Date.
Section 4.19. Possession of Franchises, Licenses, Etc. The Company and its Subsidiaries possess all franchises, certificates, licenses, permits, registrations, and other authorizations from Governmental Authorities, free from burdensome restrictions, that are necessary for the ownership, maintenance and operation of their respective properties and assets, and for the conduct of their respective businesses as now conducted, and none of the Company or any of its Subsidiaries is in violation of any thereof in any material respect.
Section 4.20. Intellectual Property.
(a) The Company and its Subsidiaries own all right, title and interest in and to, or have valid and enforceable Licenses to use, all of the Intellectual Property used by them in connection with their business as presently conducted (the “Company Intellectual Property”), which represents all intellectual property rights necessary to the conduct of the business of the Company and its Subsidiaries as now conducted and as presently contemplated to be conducted. The Company and its Subsidiaries are in compliance with the contractual obligations relating to the protection of such of the Company Intellectual Property that it uses pursuant to Licenses. To the knowledge of the Company and its Subsidiaries, there are no conflicts with or infringements by any third party of any Company Intellectual Property, and the conduct of the business of the Company and its Subsidiaries as currently conducted or as currently contemplated to be conducted does not and will not conflict with or infringe any proprietary right of any third party. There is no material claim, suit, action or proceeding pending or, to the knowledge of the Company and its Subsidiaries, threatened against the Company or any of its Subsidiaries: (i) alleging any such conflict or infringement with any third party’s proprietary rights; or (ii) challenging the ownership or use by the Company or any such Subsidiary of, or the validity or enforceability of, any Company Intellectual Property.
(b) Schedule 4.20(b) sets forth a true and complete list of all Patents, Patent applications, registered Trademarks (and applications therefor) and registered Copyrights (and applications therefor) used by Company or any of its Subsidiaries in connection with its business as presently conducted (“Listed Intellectual Property”) and the owner of record, date of
44
application or issuance and relevant jurisdiction as to each. Except as described in Schedule 4.20(b), all Listed Intellectual Property is owned by the Company and its Subsidiaries, free and clear of Liens or claims of any nature. Except as listed in Schedule 4.20(b), no Listed Intellectual Property is the subject of any legal or governmental proceeding before any governmental, registration or other authority in any jurisdiction, including any office action or other form of preliminary or final refusal of registration.
(c) Schedule 4.20(c) sets forth a true and complete list of all: (i) Licenses and other agreements in which the Company or any Subsidiary of the Company or any sublicensee of any thereof has granted to any Person the right to use the Company Intellectual Property; and (ii) all other consents, indemnifications, forbearances to sue, settlement agreements and licensing or cross-licensing arrangements to which the Company or any of its Subsidiaries is a party relating to the Intellectual Property or the proprietary rights of any third party, other than “off-the-shelf” software and the like licensed by the Company or any of its Subsidiaries as licensee. Except as set forth in Schedule 4.20(c), neither the Company nor any of its Subsidiaries is under any obligation to pay royalties or other payments in connection with any license, sublicense or other agreement, nor restricted from assigning its rights under any sublicense or agreement respecting the Company Intellectual Property nor will the Company nor any of its Subsidiaries otherwise be, as a result of the execution and delivery of this Agreement or the performance of its obligations under this Agreement, in breach of any license, sublicense or other agreement relating to the Company Intellectual Property.
(d) No present or former employee, officer or director of the Company or any of its Subsidiaries, or agent or outside contractor of the Company or any of its Subsidiaries, holds any right, title or interest, directly or indirectly, in whole or in part, in or to any Company Intellectual Property.
(e) Except as set forth on Schedule 4.20(e), to the knowledge of the Company and its Subsidiaries: (i) none of the Company Intellectual Property has been used, divulged, disclosed or appropriated to the detriment of the Company or any of its Subsidiaries for the benefit of any Person other than the Company and its Subsidiaries; and (ii) no employee, independent contractor or agent of the Company or any of its Subsidiaries has misappropriated any trade secrets or other confidential information of any other Person in the course of the performance of his or her duties as an employee, independent contractor or agent of the Company and its Subsidiaries.
(f) To the knowledge of the Company and its Subsidiaries, the Company’s and its Subsidiaries’ transmission, use, modification (including framing, if applicable), linking and other practices in respect of content proprietary to any other Person do not infringe or violate any proprietary or other right of any such Person and, to the knowledge of the Company and its Subsidiaries, no claim in respect of any such infringement or violation is threatened or pending.
Section 4.21. Software.
(a) Schedule 4.21 hereto lists the operating systems and applications computer software programs and databases used by the Company or any of its Subsidiaries that are material
45
to the conduct of their business as now conducted and as presently contemplated to be conducted, other than “off-the-shelf” software and the like licensed by the Company or any of its Subsidiaries as licensee (collectively, the “Software”), and separately identifies that portion of the Software that was developed by or under contract with the Company and its Subsidiaries (collectively, the “Proprietary Software”). The Company and its Subsidiaries: (i) hold valid licenses to use, reproduce, modify, distribute and sublicense all copies of the Software, other than the Proprietary Software, and (ii) either own, or have a perpetual, royalty-free license to use, reproduce, modify, distribute and sublicense the Proprietary Software, and, except as listed on Schedule 4.21, the Company and its Subsidiaries have not sold, licensed, leased or otherwise transferred or granted any interest or rights in or to any portion thereof. To the knowledge of the Company and its Subsidiaries, none of the Software used by the Company or any of its Subsidiaries, nor any use thereof, conflicts with, infringes upon or violates any Intellectual Property or other proprietary rights of any other Person and, to the knowledge of the Company and its Subsidiaries, no claim, suit, action or other proceeding with respect to any such infringement or violation is threatened or pending. Except as set forth on Schedule 4.21, the Company and its Subsidiaries have taken steps reasonably necessary to protect their right, title and interest in and to the Proprietary Software, including the execution of appropriate confidentiality agreements.
(b) The Company and its Subsidiaries possess or have access to the original and all copies of all documentation and all source code or password protected code, as applicable, for all the Proprietary Software owned by them. Upon consummation of the transactions contemplated by this Agreement, the Company and its Subsidiaries will continue to own all the Proprietary Software owned by them, free and clear of all claims, liens, encumbrances, obligations and liabilities other than Permitted Liens and, with respect to all agreements for the lease or license of Proprietary Software which require consents or other actions as a result of the consummation of the transactions contemplated by this Agreement in order for the Company and its Subsidiaries to continue to use and operate such Software after the Closing Date, the Company and its Subsidiaries will have obtained such consents or taken such other actions so required.
(c) Any material programs, modifications, enhancements or other inventions, improvements, discoveries, methods or works of authorship (“Works”) that were created by employees of the Company or its Subsidiaries were made in the regular course of such employees’ employment or service relationships with the Company and its Subsidiaries using the Company’s and its Subsidiaries’ facilities and resources and, as such, constitute works made for hire. Each such employee who has created Works or any employee who in the regular course of his employment may create Works and all consultants have signed an assignment or similar agreement with the Company or its Subsidiaries confirming the Company’s or such Subsidiaries’ ownership or, in the alternative, transferring and assigning to the Company or one of its Subsidiaries all right, title and interest in and to such programs, modifications, enhancements or other inventions including copyright and other intellectual property rights therein.
Section 4.22. Deposit Accounts; Securities Accounts. Schedule 4.22 hereto contains a true and complete list of all Deposit Accounts, and a separate true and complete list of all Securities Accounts maintained by the Company or any of its Subsidiaries, setting forth the name and address of each bank, savings institution or other depositary institution at which each such
46
Deposit Account is maintained and the name and address of each bank, securities broker or dealer, or other financial intermediary at which each such Securities Account is maintained, and stating the title and account number of each such Deposit Account or Securities Account (as the case may be).
Section 4.23. Interest in Competitors. Neither the Company nor any of its Subsidiaries, nor any of their respective officers or (to their knowledge) directors, has any interest, either by way of contract or by way of investment (other than as holder of not more than 2% of the outstanding Equity Interests of a publicly traded Person) or otherwise, directly or indirectly, in any Person other than the Company and its Subsidiaries that (i) provides any services or designs, produces or sells any product or product lines or engages in any activity competitive with any activity currently proposed to be conducted by the Company or any of its Subsidiaries or (ii) has any direct or indirect interest in any asset or property, real or personal, tangible or intangible, of the Company or any of its Subsidiaries.
Section 4.24. Related Party Transactions. Except as set forth in Schedule 4.24, (i) no officer, director or Affiliate of the Company or its Subsidiaries provides or causes to be provided any assets, services or facilities to the Company or its Subsidiaries, or has entered into any agreement or arrangement to provide such assets, services or facilities to the Company or its Subsidiaries (except, in the case of any such officer or director, for services provided in his or her capacity as such and agreements with respect thereto), (ii) the Company and its Subsidiaries do not provide or cause to be provided any assets, services or facilities to any such officer, director or Affiliate, and have not entered into any agreement or arrangement to provide any such assets, services or facilities to any such Persons (except, in the case of any such officer or director, for compensation and benefits paid to such Person for his or her services in such capacity in the ordinary course of business and agreements and arrangements with respect thereto), and (iii) there are no other leases, Licenses or other contracts or contractual arrangements between the Company or any of its Subsidiaries and any such officer, director or Affiliate.
Section 4.25. Registration Rights. Except as set forth in Schedule 4.25 and except as provided in the Registration Rights Agreement, neither the Company nor any of its Subsidiaries is under any obligation to register under the Securities Act any of its outstanding securities or any of its securities that may be issued subsequently.
Section 4.26. [Reserved].
Section 4.27. Existing Indebtedness and Contingent Obligations. Set forth on Schedule 4.27 is a true and complete list and brief description of (a) all Indebtedness of the Company and its Subsidiaries, specifying in each case the name and address of each Person to whom such Indebtedness is owed and the outstanding amount of the principal thereof, accrued interest thereon and any other amounts owed in connection therewith, and indicating in each case whether such Indebtedness is secured and, if so, describing the assets constituting the collateral therefor, and (b) all Contingent Obligations of the Company and its Subsidiaries, including the amounts thereof and the name and address of each Person to whom any such Contingent Obligation is owed, and indicating in each case whether such Contingent Obligation is secured and, if so, describing the assets constituting the collateral therefor. True and complete copies of
47
all credit agreements, loan agreements, mortgages, indentures, security agreements, notes, guarantees, letters of credit and other agreements, instruments and documents evidencing such Indebtedness and Contingent Obligations, with all amendments thereto, have previously been delivered to the Purchasers or their representatives.
Section 4.28. Customers. Set forth on Schedule 4.28 is a true and complete list of the names and addresses of all customers of the Company and its Subsidiaries which accounted for 5% or more of the Company’s and its Subsidiaries’ gross revenues during the fiscal year ended September 30, 2004, together with the respective percentages of the Company’s and its Subsidiaries’ gross revenues represented by each such customer. Except as set forth on Schedule 4.28, the Company has no notice or knowledge that any such customer will, or has any plan or intention to, cease to purchase products or services from the Company or its Subsidiaries or reduce to a material extent the amount of products and services it purchases from the Company or its Subsidiaries.
Section 4.29. Eligible Portfolio Company. The Company is organized under the laws of the State of Montana and has its principal place of business in the State of California. After giving effect to the transactions contemplated by this Agreement, the Company is neither an investment company as defined in Section 3 of the Investment Company Act nor a company which would be an investment company except for the exclusion from the definition of investment company in Section 3(c) of the Investment Company Act. The Company does not have any class of securities with respect to which a member of a national securities exchange, broker, or dealer may extend or maintain credit to or for a customer pursuant to rules or regulations adopted by the Board of Governors of the Federal Reserve System under Section 7 of the Exchange Act.
Section 4.30. Margin Regulations; Public Utility Holding Company Act.
(a) Neither the Company nor any of its Subsidiaries is engaged or will engage, principally or as one of its important activities, in the business of purchasing or selling Margin Stock, or extending credit for the purpose of purchasing or carrying Margin Stock. None of the proceeds of the issuance and sale of the Notes shall be used for the purpose of purchasing or carrying Margin Stock. Neither the Company nor any of its Subsidiaries, nor any agent acting on behalf of the Company or any of its Subsidiaries, has taken or will take any action which might cause this Agreement or the Notes to violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or Section 7 of the Exchange Act, in each case as in effect now or as the same may hereafter be in effect.
(b) Neither the Company nor any of its Subsidiaries is a “holding company” or a “subsidiary company” of a “holding company”, within the meaning of the Public Utility Holding Company Act of 1935, as amended.
Section 4.31. Solvency. Both immediately before and immediately after giving effect to the issuance of the Notes and the transactions contemplated by this Agreement, the Company is, individually, and the Company and its Subsidiaries on a consolidated basis are, Solvent.
48
Section 4.32. Foreign Assets Control Regulations and Anti-Money Laundering.
(a) OFAC. Neither the Company nor any Subsidiary of the Company (i) is a Person whose property or interest in property is blocked or that has been determined to be subject to blocking pursuant to Section 1 of Executive Order 13224 of September 23, 2001 Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism (66 Fed. Reg. 49079 (2001)), (ii) knowingly engages in any dealings or transactions prohibited by Section 2 of such executive order, or otherwise knowingly associates with any such person in any manner violative of Section 2, or (iii) is a Person on the list of Specially Designated Nationals and Blocked Persons published by the Office of Foreign Assets Control of the United States Department of the Treasury on June 24, 2003, as updated from time to time, or subject to the limitations or prohibitions under any other United States Department of the Treasury’s Office of Foreign Assets Control regulation or executive order.
(b) Patriot Act. The Company and each of its Subsidiaries are in compliance, in all material respects, with the Patriot Act. No part of the proceeds of the Notes will be used, directly or indirectly, for any payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United States Foreign Corrupt Practices Act of 1977, as amended.
Section 4.33. Internal Accounting Controls. The Company and its Subsidiaries have established a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
Section 4.34. Offering of Securities. None of the Company or its representatives has, directly or indirectly, offered any of the Preferred Shares, Warrants or Notes or any security similar to any of them for sale to, or solicited any offers to buy any of the Preferred Shares, Warrants or Notes or any security similar to any of them from, or otherwise approached or negotiated with respect thereto with, more than ten (10) Persons including the Purchasers, and none of the Company or its representatives has taken or will take any action which would subject the issuance or sale of any of the Preferred Shares, Warrants or Notes to the provisions of Section 5 of the Securities Act or violate the provisions of any securities or Blue Sky laws of any applicable jurisdiction.
Section 4.35. Broker’s or Finder’s Commissions. Except as set forth on Schedule 4.35 hereto, no broker’s or finder’s fee or commission will be payable by the Company with respect to the issuance and sale of the Preferred Shares, Warrants or Notes. The Company agrees to indemnify each of the Purchasers and hold each of them harmless against any loss, cost, claim or liability (including reasonable attorneys’ fees and disbursements for the investigation and defense of claims) arising out of or relating to any such actual or alleged fee or commission.
49
Section 4.36. Acquisition Transactions. The Acquisition Agreement and the other agreements and documents contemplated thereby (the “Acquisition Documents”) have been duly executed, delivered and performed in accordance with their terms by the respective parties thereto in all respects, including the fulfillment (not merely the waiver, except as may be disclosed to and consented to in writing by the Purchaser) of all conditions precedent set forth therein, the Acquisition Transactions have been completed in accordance with the terms and provisions of the Acquisition Documents, and the Company or its subsidiaries have acquired and have good and marketable title to the assets and business of SDI and SBN. All actions and proceedings required by the Acquisition Documents, applicable law or regulation (including, but not limited to, compliance with the Hart-Scott-Rodino Anti-Trust Improvements Act of 1976, as amended, if applicable) have been taken and the transactions required thereunder have been duly and validly taken and consummated. No court of competent jurisdiction has issued any injunction, restraining order or other order which prohibits consummation of the Acquisition Transactions and no governmental or other action or proceeding has been threatened or commenced, seeking any injunction, restraining order or other order which seeks to void or otherwise modify the Acquisition Transactions. The Company has delivered, or caused to be delivered, to the Purchaser true, correct and complete copies of all of the Acquisition Documents, including all amendments thereto.
Section 4.37. Disclosure. Neither this Agreement nor any other document, certificate or statement furnished to the Purchasers by or on behalf of the Company in connection herewith, contained, as of its respective date, or now contains, any untrue statement of a material fact or as of any such date omitted, or now omits, to state a material fact necessary in order to make the statements contained herein and therein not misleading.
Section 5. Representations of Purchasers. Each of the Purchasers represents to the Company that (a) it is an “accredited investor,” within the meaning of Rule 501 promulgated by the SEC under the Securities Act, and (b) it is acquiring the Notes to be purchased by it hereunder for its own account, for investment, and not with a view to or for sale in connection with any distribution thereof in violation of the registration provisions of the Securities Act or the rules and regulations promulgated thereunder.
Section 6. [Reserved]
Section 7. Financial Statements and Information. The Company will furnish to each Purchaser, so long as it shall hold any Notes, and, in the case of the items referred to in subsections (a), (b), (c)(i), (f) and (g) of this Section 7, so long as it shall hold any Warrants or any shares of Company Common Stock issued upon the exercise of Warrants:
(a) Monthly Financials. As soon as available and in any event within 30 days after the end of each of month, copies of the unaudited consolidated and consolidating balance sheets of the Company and its Subsidiaries as of the end of such month, and of the related unaudited consolidated and consolidating statements of income, retained earnings and cash flows for such month and for the portion of the fiscal year ended with the last day of such month, all in reasonable detail and stating in comparative form (i) the consolidated and consolidating figures as of the end of and for the corresponding date and month in the previous fiscal year and (ii) the
50
corresponding figures from the consolidated budget of the Company and its Subsidiaries for such period, all Certified by the Chief Financial Officer of the Company.
(b) Quarterly Financial Statements. As soon as available and in any event within 45 days after the end of each fiscal quarter of the Company, copies of the unaudited consolidated and consolidating balance sheets of the Company and its Subsidiaries as of the end of such fiscal quarter, and of the related unaudited consolidated and consolidating statements of income, retained earnings and cash flows for such fiscal quarter and for the portion of the fiscal year ended with the last day of such fiscal quarter, all in reasonable detail and stating in comparative form (i) the consolidated and consolidating figures as of the end of and for the corresponding date and fiscal quarter in the previous fiscal year and (ii) the corresponding figures from the consolidated budget of the Company and its Subsidiaries for such period, all Certified by the Chief Financial Officer of the Company.
(c) Annual Financial Statements. As soon as available and in any event within 90 days after the end of each fiscal year of the Company,
(i) copies of the audited consolidated and unaudited consolidating balance sheets of the Company and its Subsidiaries as of the end of such fiscal year, and of the related audited consolidated and unaudited consolidating statements of income, retained earnings and cash flows for such fiscal year, together with the notes thereto, all in reasonable detail and stating in comparative form (A) the respective audited consolidated and unaudited consolidating figures as of the end of and for the previous fiscal year and (B) the corresponding figures from the consolidated budget of the Company and its Subsidiaries for such fiscal year furnished pursuant to Section 7(n), (x) in the case of such audited consolidated financial statements, accompanied by a report thereon of the Accountants, which report shall be unqualified as to going concern and scope of audit and shall state that such consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company and its Subsidiaries as at the end of such fiscal year and the consolidated results of their operations, retained earnings and cash flows for such fiscal year in accordance with GAAP applied on a basis consistent with prior years (except as otherwise stated therein) and that the examination by the Accountants in connection with such consolidated financial statements has been made in accordance with generally accepted auditing standards, and (y) in the case of such unaudited consolidating financial statements, Certified by the Chief Financial Officer of the Company; and
(ii) a written statement of the Accountants that (A) based upon their review of the statements with respect to financial covenants contained in the Compliance Certificate furnished by the Company as of the end of such fiscal year, they have no reason to believe that such statements are not true and accurate in all material respects, and (B) in making the examination necessary for their report on such financial statements they obtained no knowledge of any Default or Event of Default that occurred or existed during such fiscal year, or if such Accountants shall have obtained knowledge of any such Default or Event of Default, specifying the nature and status thereof.
51
(d) Compliance Certificate. Concurrently with each of the quarterly and annual financial statements furnished pursuant to Section 7(b) and Section 7(c), a Compliance Certificate properly completed as of the last day of the applicable fiscal quarter or fiscal year and signed by the Chief Financial Officer of the Company.
(e) Bank Statements. Promptly after receipt thereof, copies of monthly statements for each of the Deposit Accounts and Securities Accounts maintained by the Company and each of its Subsidiaries.
(f) Shareholder Reports. Promptly after the same are available and in any event within 15 days thereof, copies of all such proxy statements, financial statements, notices and reports as the Company or any of its Subsidiaries shall send or make available generally to their securityholders, and copies of all regular and periodic reports and of all registration statements (other than on Form S-8 or a similar form) which the Company or any of its Subsidiaries may file with the SEC or with any securities exchange.
(g) Management Letters. Promptly after the receipt thereof by the Company or any of its Subsidiaries, and in any event within 15 days thereof, copies of any management letters and any reports as to material inadequacies in accounting controls (including reports as to the absence of any such inadequacies) submitted to the Company by the Accountants in connection with any audit thereof made by the Accountants.
(h) Notice of Default. Promptly (and in any event within 5 Business Days) after any Responsible Officer of the Company or any of its Subsidiaries has knowledge of (1) the existence of any Default or Event of Default on the part of the Company, an Officer’s Certificate of the Company specifying the nature and period of existence thereof and what action the Company is taking or proposes to take with respect thereto; or (2) any Indebtedness of the Company or any of its Subsidiaries being declared due and payable before its expressed maturity, or any holder of such Indebtedness having the right to declare such Indebtedness due and payable before its expressed maturity, because of the occurrence of any default (or any event which, with notice and/or the lapse of time, shall constitute any such default) under such Indebtedness, an Officer’s Certificate of the Company describing the nature and status of such matters and what action the Company or such Subsidiary is taking or proposes to take with respect thereto.
(i) Regulatory and Intellectual Property Filings. As soon as reasonably practicable but in any event within five (5) Business Days after receipt or delivery thereof, (i) copies of any and all material notices and other material communications received by and the Company or its Subsidiaries from, or sent by the Company to, any federal or state regulatory body with jurisdiction over the Company’s or such Subsidiary’s products, services, business and/or processes with respect to the Company or any of its Subsidiaries or any of their respective products, services or practices and (ii) copies of all filings by the Company or its Subsidiaries with the United States Patent and Trademark Office or the United States Copyright Office with respect to any Intellectual Property of the Company or its Subsidiaries, all non-infringement opinions of counsel or advisors to the Company or its Subsidiaries pertaining thereto and all material Licenses entered into by the Company or its Subsidiaries in respect thereof (whether as licensor or licensee).
52
(j) Notice of Infringement Claims. As soon as reasonably practicable and in any event within five (5) Business Days after a Responsible Officer of the Company has knowledge of the assertion by or against the Company or any of its Subsidiaries of any claim for, or the actual or threatened commencement of any judicial, administrative or arbitral action, suit or proceeding by or against the Company or any of its Subsidiaries with respect to, (i) any actual or alleged infringement by any third party of any Patent, Trademark, Copyright or other Intellectual Property or rights relating thereto owned or used by the Company or any of its Subsidiaries, (ii) any actual or alleged infringement by the Company or any of its Subsidiaries of any Patent, Trademark, Copyright or other Intellectual Property or rights relating thereto owned or used by any third party, or (iii) any actual or alleged breach or violation of any License to which the Company or any of its Subsidiaries is a party, whether by the Company or any of its Subsidiaries or by any other party thereto, an Officer’s Certificate of the Company describing the nature and status of such matter in reasonable detail.
(k) Notice of Litigation. Promptly (and in any event within 15 days) after the Company has knowledge of (i) the institution of, or threat of, any action, suit, proceeding, governmental investigation or arbitration against or affecting the Company or any of its Subsidiaries or any property of any of them, or (ii) any material development in any such action, suit, proceeding, governmental investigation or arbitration, which, in either case, if adversely determined, is likely to have a Material Adverse Effect, an Officer’s Certificate of the Company describing the nature and status of such matter in reasonable detail.
(l) ERISA Notices. Promptly after any Responsible Officer of the Company or any of its Subsidiaries has knowledge of any of the following events if the same would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect, an Officer’s Certificate describing the nature and status of such event, together with a copy of any notice with respect to such event that may be required to be filed with a Governmental Authority and any notice delivered by a Governmental Authority to the Company or any ERISA Affiliate with respect to such event:
(i) an ERISA Event;
(ii) the adoption of any new Pension Plan by the Company or any ERISA Affiliate;
(iii) the adoption of any amendment to a Pension Plan, if such amendment results in a material increase in benefits or unfunded liabilities; or
(iv) the commencement of contributions by the Company or any ERISA Affiliate to any Multiemployer Plan or any Pension Plan.
(m) Notice of Material Adverse Effect. Promptly after any Responsible Officer of the Company or any of its Subsidiaries has knowledge of any Material Adverse Effect with respect to which notice is not otherwise required to be given pursuant to this Section 7, an Officer’s Certificate of the Company setting forth the details of such Material Adverse Effect and stating
53
what action the Company or any of its Subsidiaries has taken or proposes to take with respect thereto.
(n) Annual Budget. Not later than 30 days prior to the beginning of each fiscal year, an annual operating budget of the Company and its Subsidiaries, on both a consolidated and consolidating basis, (i) for such fiscal year, containing projections of profit and loss, cash flow and ending balance sheets for each month of such fiscal year, and (ii) for the succeeding two (2) years, containing projections of profit and loss, cash flow and ending balance sheets for each of such years; and thereafter, promptly upon preparation thereof, all amendments and revisions thereto which may be made from time to time.
(o) Annual Insurance Report. At least once in each fiscal year, a report of a reputable insurance broker with respect to all insurance maintained by the Company and its Subsidiaries, together with a certificate of insurance evidencing the effectiveness of the policies of insurance required to be maintained by the provisions of Section 9.6(a).
(p) Certain Changes and Conduct of Business. Promptly after the occurrence thereof, notice of all material developments in the assets, liabilities, ownership, operations or business of the Company and its Subsidiaries, including (i) any issuance of debt securities or incurrence of any Indebtedness by the Company or any of its Subsidiaries, (ii) a change in the number of members of the board of directors of the Company, (iii) a sale, lease or transfer of any material portion of the assets of the Company or any of its Subsidiaries, other than in the ordinary course of business, (iv) an acquisition of the Equity Interests of any Person, or of any material assets of any Person or division or line of business of any Person, other than in the ordinary course of business, and (v) any change in the outstanding number or ownership of the shares of Company Common Stock or Company Preferred Stock (specifying the details of any such change, including the identity and ownership amount of any new owner). The Company shall provide the Purchasers with any written information provided to the board of directors or board of managers (or similar body) of the Company or any of its Subsidiaries in their respective capacities as such.
(q) Related Party Transactions. Within 90 days after the end of each fiscal year, a report describing in reasonable detail the nature and amount of (i) all transactions of the type disclosed in Schedule 4.24 engaged in by the Company and its Subsidiaries during such fiscal year, and (ii) all other transactions during such fiscal year between the Company or its Subsidiaries and any officer, director or Affiliate of the Company or any such Subsidiary, other than compensation and benefits paid by the Company and its Subsidiaries to their officers, directors and employees in the ordinary course of business consistent with past practice.
(r) Other Information. Any other information, including financial statements and computations, relating to the performance of Obligations arising under this Agreement or the other Note Documents, or the assets, liabilities, business, operations or prospects of the Company or any of its Subsidiaries, that the Majority Purchasers may from time to time reasonably request and which is capable of being obtained, produced or generated by the Company or such Subsidiary or of which any of them has knowledge.
54
Section 8. Inspection Rights; Board Observation Rights.
Section 8.1. Inspection of Books and Properties. So long as any Notes shall be outstanding, the Collateral Agent and its representatives and independent contractors shall have the right to visit and inspect any of the properties and locations of the Company and its Subsidiaries, to examine their books of account and Records, to make copies and extracts therefrom at their expense, and to discuss their affairs, finances and accounts with, and to be advised as to the same by, their officers and employees and their independent public accountants, all at such reasonable times during normal business hours as the Collateral Agent may desire, upon reasonable advance notice to the Company and at the sole cost and expense of the Collateral Agent; provided that, during the continuance of any Default or Event of Default, the Collateral Agent and its representatives and independent contractors shall have the right to do any of the foregoing at the expense of the Company at any time during normal business hours and without advance notice.
Section 8.2. Board of Directors; Observation Rights. The Company shall cause its board of directors to hold a meeting at least once during each fiscal quarter of the Company. So long as any Notes shall be outstanding, the Collateral Agent may at its option designate by written notice to the Company a representative (the “Observer”), who shall have the right to attend all meetings of the board of directors of the Company and of any Subsidiary thereof, and of any committees of such boards of directors, without voting on or consenting to any matters presented at such meetings. The Observer shall be entitled to receive copies of all notices of meetings of the board of directors of the Company or any such Subsidiary and of any such committee, and all written materials distributed to members thereof in connection with such meetings, in each case at the same time and in the same manner as the members of such board of directors or committee (as the case may be) receive such notices or materials. If such board of directors or committee proposes to take any action by written consent in lieu of a meeting, the Company will give written notice thereof to the Observer prior to the effective date of such consent describing in reasonable detail the nature of such action, together with copies of any written materials distributed to directors in connection therewith.
Section 9. Affirmative Covenants. The Company covenants and agrees that so long as any of the Notes shall be outstanding:
Section 9.1. Payment of Principal, Prepayment Charge and Interest. The Company will duly and punctually pay the principal of, prepayment charge (if any) and interest on the Notes in accordance with the terms of such Notes and this Agreement. The Company will comply with all of the covenants, agreements and conditions contained in this Agreement.
Section 9.2. Maintenance of Corporate Existence, Properties and Records. The Company will, and will cause each of its Subsidiaries to:
(a) do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, rights, powers and franchises including any necessary qualification or licensing in any foreign jurisdiction, provided that the Company may effect a Permitted Change of Jurisdiction;
55
(b) maintain its properties in good condition, reasonable wear and tear excepted, and make all necessary renewals, repairs, replacements, additions, betterments, and improvements thereto;
(c) preserve or renew all of its Patents, Trademarks, Copyrights, Licenses and other Intellectual Property, the non-preservation of which would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect, and conduct its business and affairs without infringement of or interference with any Intellectual Property of any other Person in any material respect;
(d) keep books of account and other Records in which full and correct entries will be made of all of its business transactions, and reflect in its financial statements adequate accruals and appropriations to reserves, all in accordance with GAAP; and
(e) maintain the same fiscal year during and after the current fiscal year ending September 30, 2005.
Section 9.3. Payment of Taxes and Claims. The Company will, and will cause each of its Subsidiaries to, pay before they become delinquent:
(a) all taxes, assessments and governmental charges or levies imposed upon the Company or any of its Subsidiaries or their income or profits or upon their property, real, personal or mixed, or upon any part thereof;
(b) all claims for labor, materials and supplies which, if unpaid, might result in the creation of a Lien upon property of the Company or any of its Subsidiaries; and
(c) all claims, assessments, or levies required to be paid by the Company or any of its ERISA Affiliates pursuant to any Plan or Multiemployer Plan or any agreement, contract or Requirement of Law governing or relating to any such plan;
Section 9.4. Compliance With Law. The Company will, and will cause each of its Subsidiaries to comply with all applicable Requirements of Law, franchises, authorizations, licenses and permits of, and all applicable restrictions imposed by, any Governmental Authority in respect of the conduct of its business and the ownership of its properties (including all Environmental Laws and all applicable Requirements of Law, franchises, authorizations, licenses and permits relating to fair labor standards, equal employment opportunities and occupational health and safety), including the timely filing or distribution to the Company’s stockholders of all
56
reports and statements which the Company is required to so file or distribute under the Exchange Act, the rules and regulations of the SEC promulgated thereunder or the applicable rules of any securities market on which the Company Common Stock is listed.
Section 9.5. Environmental Matters. The Company will, and will cause each of its Subsidiaries to: (a) conduct its operations and keep and maintain all real property owned or used by it in compliance with all Environmental Laws and Environmental Permits other than noncompliance that could not reasonably be expected to have a Material Adverse Effect; (b) implement any and all investigations, remediations, removals and response actions that are appropriate or necessary to maintain the value and marketability of such real property or to otherwise comply with Environmental Laws and Environmental Permits pertaining to the presence, generation, treatment, storage, use, disposal, transportation or Release of any Hazardous Material on, at, in, under, above, to, from or about any of such real property; (c) notify the Collateral Agent promptly after any Responsible Officer of the Company or any of its Subsidiaries has knowledge of any violation of Environmental Laws or Environmental Permits or any Release on, at, in, under, above, to, from or about any such real property that is reasonably likely to result in liabilities in excess of $50,000 in the aggregate; and (d) promptly forward to the Collateral Agent a copy of any order, notice, request for information or any communication or report received by the Company or any of its Subsidiaries in connection with any such violation or Release or any other matter relating to any Environmental Laws or Environmental Permits that could reasonably be expected to result in liabilities in excess of $50,000 in the aggregate, in each case whether or not the Environmental Protection Agency or any Governmental Authority has taken or threatened any action in connection with any such violation, Release or other matter. If the Collateral Agent at any time has a reasonable basis to believe that there may be a violation of any Environmental Laws or Environmental Permits by any the Company or any of its Subsidiaries or any liability arising thereunder, or a Release of Hazardous Materials on, at, in, under, above, to, from or about any of such real property, that, in each case, could reasonably be expected to have a Material Adverse Effect, then upon the Collateral Agent’s written request the Company shall, and shall cause its Subsidiaries to, (i) cause the performance of such environmental audits including subsurface sampling of soil and groundwater, and preparation of such environmental reports, at the Company’s expense, as the Collateral Agent may from time to time reasonably request, which shall be conducted by reputable environmental consulting firms reasonably acceptable to the Collateral Agent and shall be in form and substance reasonably acceptable to the Collateral Agent, and (ii) permit the Collateral Agent or its representatives to have access to all such real property for the purpose of conducting such environmental audits and testing as the Collateral Agent deems appropriate, including subsurface sampling of soil and groundwater. The Company shall reimburse the Collateral Agent upon demand for the costs of such audits and tests.
Section 9.6. Insurance.
(a) The Company shall maintain, and shall cause each of its Subsidiaries to maintain, with independent insurers reasonably believed by the Company to be financially sound and reputable, (i) property damage and casualty insurance on all real and personal property of the Company and its Subsidiaries on an all risks basis, covering the repair and replacement cost of all such property, and (ii) other insurance with respect to its business against loss or damage of the
57
kinds customarily insured against by Persons engaged in the same or similar business, of such types and in such amounts as are customarily carried under similar circumstances by such other Persons, including in any event workers’ compensation insurance, public liability (including products/completed operations liability coverage) and business interruption insurance. The coverage amounts of such insurance shall not be reduced by the Company or any of its Subsidiaries in the absence of thirty (30) days’ prior written notice to the Collateral Agent. All property damage and casualty insurance shall name the Collateral Agent as lender loss payee/mortgagee, all liability insurance shall name the Collateral Agent as an additional insured and all business interruption insurance shall name the Collateral Agent as assignee.
(b) If the amount of any insurance proceeds received by the Company or its Subsidiaries, or by the Collateral Agent, in respect of any occurrence of loss or damage to Collateral or other property of the Company or its Subsidiaries is less than $100,000 and no Default or Event of Default shall have occurred and be continuing, such proceeds shall be retained by the Company or such Subsidiary (or released to them by the Collateral Agent, as the case may be) and used to pay for the repair, replacement or reconstruction of the Collateral or other property subject to such loss or damage. If the amount of such insurance proceeds is equal to or greater than such amount or if a Default or Event of Default shall have occurred and be continuing, then such proceeds shall be immediately paid over to the Collateral Agent (or retained by the Collateral Agent, as the case may be) on behalf of the Purchasers and applied to the prepayment of the Indebtedness incurred hereunder in accordance with the provisions of Section 3.1(b).
Section 9.7. After Acquired Real Property. Without affecting the Obligations of the Company or any of its Subsidiaries under any of the Security Documents, in the event that the Company or any of its Subsidiaries at any time after the date hereof acquires any material interest (including a leasehold interest) in any real property, or any Person having such an interest in real property shall become a New Subsidiary (each such interest, an “After Acquired Real Property”), the Company shall immediately provide written notice thereof to the Collateral Agent, setting forth with specificity a description of the interest acquired, the location of the After Acquired Real Property, any structures or improvements thereon and the fair market value of such real property. As soon as practicable thereafter, the Company shall execute and deliver, or shall cause the Person holding such After Acquired Real Property (if other than the Company) to execute and deliver, to the Collateral Agent a Mortgage on such After Acquired Real Property together with such other Mortgage Documents relating thereto as the Collateral Agent shall reasonably require. The Company shall also deliver to the Collateral Agent one or more opinions of counsel for the Company or such Subsidiary (including opinions of local counsel) covering such legal matters with respect to such Mortgage Documents as the Collateral Agent may reasonably request. The Company shall pay all fees and expenses, including attorneys’ fees and expenses of counsel for the Collateral Agent, and all title insurance charges and premiums, in connection with its Obligations under this Section 9.7.
Section 9.8. Future Subsidiaries. If any Person which is not a Subsidiary of the Company on the date hereof shall hereafter become a direct or indirect Subsidiary of the Company (each a “New Subsidiary”), the Company shall, not later than the date on which such Person becomes such a Subsidiary of the Company, (a) provide written notice to the Collateral
58
Agent of the formation or acquisition of the New Subsidiary by the Company or its Subsidiaries, which notice shall describe in reasonable detail the New Subsidiary, its operations and assets and the nature and ownership of its outstanding Equity Interests, (b) deliver to the Collateral Agent stock certificates or other certificates representing all of the outstanding Equity Interests of the New Subsidiary held by the Company and its Subsidiaries, accompanied by appropriate stock powers or other assignments duly executed in blank by the Company or such Subsidiaries (as the case may be), and (c) shall promptly cause the New Subsidiary to deliver to the Collateral Agent:
(i) an Assumption Agreement in the form attached as Annex 1 to the Subsidiary Guarantee, duly executed by the New Subsidiary;
(ii) an Assumption Agreement in the form attached as Annex 1 to the Security Agreement, duly executed by the New Subsidiary;
(iii) Mortgage Documents with respect to each After Acquired Real Property of the New Subsidiary, and all other items required by Section 9.7 with respect thereto;
(iv) all other Security Documents and other documents which may be required under applicable law, or which the Collateral Agent may reasonably request, in order to grant, preserve, protect and perfect the validity and first priority of the Liens and security interests created by the Security Documents in the Collateral of such New Subsidiary, each duly executed by the New Subsidiary; and
(v) one or more opinions of counsel (including opinions of local counsel) covering such legal matters with respect to the foregoing agreements and documents as the Collateral Agent may reasonably request.
Section 9.9. Use of Proceeds. The proceeds from the sale and issuance of the Preferred Shares, Notes and Warrants will be used solely (a) to retire existing Indebtedness of the Company and its Subsidiaries, (b) to pay all or part of the purchase price of the Acquisition and fees and expenses incurred by the Company or its Subsidiaries in connection therewith, and (c) for general corporate purposes. The Company shall provide each SBIC Investor and the SBA reasonable access to the Company’s books and records for the purpose of confirming the use of proceeds from the sale of the Preferred Shares, Notes and Warrants.
Section 9.10. Registration Statement. Within 30 days after the Closing Date, the Company will file with the SEC either (i) a registration statement on Form 10-SB under the Exchange Act with respect to the Company Common Stock or (ii) a registration statement on Form SB-2 under the Securities Act (either such registration statement, as filed and as from time
59
to time amended, the “Registration Statement”). The Registration Statement will comply in all material respects as to form with the applicable requirements of the Exchange Act or the Securities Act (as the case may be) and the rules promulgated by the SEC thereunder, and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading. Following the filing of the Registration Statement, the Company will take all such actions with respect to thereto (including responding promptly and appropriately to any comments on such registration statement received from the SEC) that may be reasonably required in order to induce the SEC to declare the Registration Statement effective at the earliest practicable date.
Section 9.11. SBIC Covenants.
(a) So long as any SBIC Investor holds any securities of the Company, the Company will at all times comply with the non-discrimination requirements of 13 C.F.R. Parts 112, 113 and 117.
(b) Within forty-five (45) days after the end of each fiscal year of the Company and at such other times as an SBIC Investor may reasonably request, the Company shall deliver to each SBIC Investor a written assessment, in form and substance satisfactory to such SBIC Investor, of the economic impact of such SBIC Investor’s financing specifying the full-time equivalent jobs created or retained in connection with such investment, and the impact of the financing on the Company’s business in terms of profits and on taxes paid by the Company and its employees. Upon request, the Company agrees to promptly provide each SBIC Investor with sufficient information to permit such SBIC Investor to comply with their obligations under the Small Business Investment Act of 1958, as amended, and the regulations promulgated thereunder and related thereto. Any submission of any financial information under this Section shall include a certificate of the Company’s president, chief executive officer, treasurer or chief financial officer.
Section 9.12. Further Assurances. The Company will, and will cause its Subsidiaries to, from time to time execute, deliver, record, register and file any and all further documents, financing statements, security agreements, assignments, mortgages, deeds of trust, and other instruments and documents, and take all further actions (including filing Uniform Commercial Code financing statements), which may be required under applicable law, or which the Collateral Agent may reasonably request, in order to grant, preserve, protect and perfect the validity and first priority of the Liens and security interests created by the Security Documents and otherwise to effectuate the transactions contemplated by this Agreement and the other Note Documents.
Section 10. Negative Covenants. The Company covenants and agrees that so long as any of the Notes shall be outstanding:
Section 10.1. Restrictions on Indebtedness. The Company will not, and will not permit any of its Subsidiaries to, incur, create, assume, guarantee or in any way become liable for, or permit to exist, Indebtedness other than:
(a) Indebtedness represented by the Notes;
60
(b) Indebtedness of the Company and its Subsidiaries existing on the Closing Date and listed on Schedule 4.27;
(c) Purchase Money Indebtedness incurred to finance Capital Expenditures permitted by Section 11.1; provided that the principal amount of Purchase Money Indebtedness incurred pursuant to this Section 10.1(c) shall not exceed $500,000 in the aggregate at any time outstanding; and
(d) Indebtedness of any Wholly-owned Subsidiary of the Company to the Company or to another Wholly-owned Subsidiary of the Company.
Section 10.2. Restrictions on Liens. The Company will not, and will not permit any of its Subsidiaries to, directly or indirectly, create, assume or suffer to exist any Lien upon any of their respective properties or assets whether now owned or hereafter acquired, except for the following (the “Permitted Liens”):
(a) Liens for taxes, assessments, governmental charges or claims the payment of which is not at the time required by Section 9.3;
(b) statutory Liens of landlords and Liens of carriers, warehousemen, mechanics, materialmen and other Liens imposed by law incurred in the ordinary course of business for sums, the payment of which is not at the time required by Section 9.3;
(c) Liens (other than any Lien imposed by ERISA, and other than any Lien securing an obligation for the payment of borrowed money or for the deferred purchase price of property or services) incurred or deposits made in the ordinary course of business in connection with obligations not due or delinquent with respect to workers’ compensation, unemployment insurance and other types of social security, or to secure the performance of tenders, statutory obligations, surety and appeal bonds, bids, leases, government contracts, performance and return-of-money bonds and other similar obligations;
(d) attachment or judgment Liens (including judgment or appeal bonds) not exceeding $100,000 in the aggregate at any time outstanding, provided that any such Lien shall, within 30 days after the entry thereof, have been discharged or execution thereof stayed pending appeal, or shall have been discharged within 30 days after the expiration of any such stay;
(e) zoning restrictions, easements, licenses, reservations, restrictions on the use of real property or minor irregularities incident thereto (and, with respect to leasehold interests, Liens and other encumbrances that are incurred, created, assumed or permitted to exist on or with respect to the leased property and arise by, through or under or are asserted by a landlord or owner of the leased property, with or without consent of the lessee) which were not incurred in connection with the borrowing of money and which do not in the aggregate materially detract from the value of the property of the Company or any of its Subsidiaries, as the case may be, or impair the use of such property for the purposes for which such property is held by the Company or any such Subsidiary;
61
(f) Liens securing Indebtedness of a Wholly-owned Subsidiary of the Company to the Company or to another Wholly-owned Subsidiary of the Company;
(g) Liens existing on the Closing Date (other than any such Liens that secure Purchase Money Indebtedness);
(h) Liens securing Purchase Money Indebtedness incurred in connection with the purchase, acquisition or construction by the Company or its Subsidiaries of real property, improvements thereto, equipment or other fixed assets or intangibles (including software); provided that (i) such security interests secure Indebtedness permitted by Section 10.1(c), (ii) such security interests are incurred, and the Indebtedness secured thereby is created, within one year after such acquisition (or construction), (iii) the Indebtedness secured thereby does not exceed the fair market value of such real property, improvements or equipment at the time of such acquisition (or construction) and (iv) such security interests do not apply to any other property or assets (other than accessions to such real property, improvements or equipment) of the Company or any of its Subsidiaries;
(i) any Lien on property of a Subsidiary of the Company existing at the time it becomes such a Subsidiary;
(j) the Liens created by the Security Documents; and
(k) the extension, renewal or replacement of any Lien permitted by subsection (g), (h) or (i) of this Section 10.2, but only if the principal amount of the Indebtedness secured by such Lien immediately prior to such extension, renewal or replacement is not increased and the Lien is not extended to other property.
Section 10.3. Limitation on Sale and Leasebacks. The Company will not, and will not permit any of its Subsidiaries to:
(a) enter into any Sale and Leaseback Transaction other than any Sale and Leaseback Transaction for which the lease is a Capitalized Lease and the Capitalized Lease is permitted under Section 10.1(c); or
(b) enter into any Synthetic Lease.
Section 10.4. Mergers, Consolidations, Sales of Assets and Acquisitions. The Company will not, and will not permit any of its Subsidiaries to, (i) consolidate with or be a party to a merger with any other Person, or (ii) sell or otherwise Dispose of any or all of the assets of the Company and its Subsidiaries, or any of the Equity Interests of any direct or indirect Subsidiary of the Company, or (iii) acquire by purchase or otherwise a majority of any class of the Equity Interests of any Person, or all or substantially all of the business or property of any Person or of any operating division or line of business of any Person, except as follows:
(a) any Wholly-owned Subsidiary of the Company may merge or consolidate with or into the Company or with or into any other Wholly-owned Subsidiary of the Company so long as
62
in any merger or consolidation involving the Company, the Company shall be the surviving or continuing corporation;
(b) the Company may effect a Permitted Change of Jurisdiction;
(c) the Company or any Wholly-owned Subsidiary of the Company may merge or consolidate with a Person acquired pursuant to a Permitted Acquisition, so long as, in the case of any such merger by the Company, the Company shall be the surviving or continuing corporation;
(d) the Company or any Wholly-owned Subsidiary of the Company may purchase or acquire all of the Equity Interests of a Person, or all or substantially all of the assets of a Person or of a division or line of business of a Person, pursuant to a Permitted Acquisition;
(e) the Company and any of its Subsidiaries may, in the ordinary course of its business, sell or otherwise Dispose of Inventory owned by the Company or such Subsidiary and grant non-exclusive licenses on Intellectual Property owned by the Company or such Subsidiary;
(f) the Company and any of its Subsidiaries may sell or otherwise Dispose of obsolete or worn out property in the ordinary course of business, in an amount not to exceed $150,000 in the aggregate during any fiscal year of the Company;
(g) any Subsidiary of the Company may sell, lease or otherwise Dispose of all or any part of its assets to the Company or any Wholly-owned Subsidiary of the Company; and
(h) the Company and its Subsidiaries may sell or otherwise Dispose of assets other than in the ordinary course of business (excluding Equity Interests in any direct or indirect Subsidiary of the Company) if (i) the consideration received by the Company and its Subsidiaries in respect of any such sale or other Disposition shall be not less than the fair market value of the assets thereby sold or Disposed of, (ii) at least seventy-five percent (75%) of the aggregate sales price of such sale or other Disposition shall be paid in Cash or Cash Equivalents, (iii) both immediately before and immediately after giving effect to such sale or other Disposition, no Default or Event of Default shall have occurred and be continuing, and (iv) the aggregate fair market value of all assets sold or otherwise Disposed of by the Company and its Subsidiaries pursuant to this subsection (h) in any fiscal year of the Company shall not exceed $150,000.
Section 10.5. Conduct of Business. The Company will not, and will not permit any of its Subsidiaries to, engage in any business or activities other than the Business and any businesses or activities substantially similar or related thereto. Without limiting the foregoing, for a period of one year following the issuance of a Note to an SBIC Investor pursuant to this Agreement, the Company shall not change the nature of its business activities if such change would render the Company ineligible as provided in 13 C.F.R. Section 107.720.
63
Section 10.6. Restricted Payments and Restricted Investments. The Company will not, will not permit any of its Subsidiaries to, directly or indirectly make any Restricted Payment or Restricted Investment, except:
(a) payments to any of the Purchasers required by the provisions of this Agreement or the Stock Purchase Agreement;
(b) the declaration and payment of dividends and distributions by a Wholly-owned Subsidiary of the Company on its outstanding Equity Interests to the Company or to another Wholly-owned Subsidiary of the Company; and
(c) Investments made as part of a Permitted Acquisition.
Section 10.7. Disqualified Redeemable Stock; Issuance of Stock by Subsidiaries.
(a) The Company will not issue or at any time have outstanding any Disqualified Redeemable Stock or any options, warrants or other rights to subscribe for or purchase Disqualified Redeemable Stock.
(b) The Company will not permit any Subsidiary of the Company to (i) issue, sell or otherwise Dispose of any shares of its common stock or other Common Equity Interests, or any warrants, options, conversion rights or other rights to subscribe for, purchase or acquire such common stock or other Common Equity Interests (other than directors’ qualifying shares, to satisfy preemptive rights or in connection with a split or combination of shares or a dividend payable in shares of the same class of common stock or other Common Equity Interests), except to the Company or to a Wholly-owned Subsidiary of the Company, or (ii) issue or have outstanding any of its shares of preferred stock or other Preferred Equity Interests (or any warrants, options, conversion rights or other rights to subscribe for, purchase or acquire such preferred stock or other Preferred Equity Interests) other than shares of such preferred stock or Preferred Equity Interests owned by the Company or a Wholly-owned Subsidiary of the Company.
Section 10.8. Transactions with Affiliates. Except in the case of (i) transactions among the Company and its Wholly-owned Subsidiaries, (ii) payments of reasonable fees, compensation and benefits consistent with past practice, and provision of reasonable indemnification, to officers, employees, consultants and agents of the Company and its Subsidiaries for actual services rendered to the Company and its Subsidiaries in the ordinary course of business, all as determined by the board of directors or senior management of the Company in good faith, (iii) payments made pursuant to and in accordance with the provisions of the Employment Agreements, (iv) payments to directors of the Company and its Subsidiaries of reasonable fees for service in such capacity consistent with past practice and reimbursement of actual out-of-pocket expenses incurred in connection with attending meetings of the boards of directors of the Company and its Subsidiaries and committees thereof, and provision of reasonable indemnification to such directors, all as determined by the board of directors of the Company in good faith, and (v) a Permitted Change of Jurisdiction, the Company will not, and will not permit any of its Subsidiaries to, directly or indirectly, enter into or permit to exist any transaction
64
(including the purchase, sale, lease or exchange of any property or the rendering of any service), with any Affiliate of the Company or such Subsidiary unless such transaction is otherwise permitted under this Agreement, is in the ordinary course of the Company’s or such Subsidiary’s business and is on fair and reasonable terms that are not less favorable to the Company or such Subsidiary, as the case may be, than those that would be obtainable at the time in an arms’ length transaction with a Person who is not such an Affiliate.
Section 10.9. Operating Leases. The Company will not, and will not permit any of its Subsidiaries to, enter into (as lessee) any lease of real or personal property (other than Capitalized Leases) having a term greater than one year (including options to renew or extend any term, whether or not exercised) if, after giving effect thereto, the aggregate amount of rentals and other payments required to be made by the Company and its Subsidiaries during any fiscal year of the Company under all such leases would be greater than $250,000.
Section 10.10. Contingent Obligations. The Company will not, and will not or permit any of its Subsidiaries to, create, incur, assume or suffer to exist any Contingent Obligations except:
(a) Contingent Obligations incurred pursuant to this Agreement and the other Note Documents;
(b) Swap Contracts entered into in the ordinary course of business for bona fide hedging purposes and not for purposes of speculation;
(c) Contingent Obligations of the Company and its Subsidiaries existing as of the Closing Date and listed in Schedule 4.27, including extensions and renewals thereof which do not increase the amount of such Contingent Obligations as of the date of such extension or renewal;
(d) Contingent Obligations incurred in the ordinary course of business with respect to surety and appeal bonds, performance bonds and other similar obligations (exclusive of obligations for the payment of borrowed money);
(e) Contingent Obligations resulting from endorsements for collection or deposit in the ordinary course of business;
(f) Contingent Obligations arising under indemnity agreements to title insurers to cause such title insurers to issue title insurance policies required hereunder; and
(g) Contingent Obligations arising with respect to customary indemnification obligations in favor of purchasers in connection with Dispositions permitted under Section 10.4(h).
Section 10.11. Limitation on Dividend Restrictions Affecting Subsidiaries. Except pursuant to this Agreement, the Company will not permit any of its Subsidiaries directly or indirectly to create or otherwise cause or suffer to exist or become effective any consensual encumbrance or restriction which by its terms restricts the ability of any such Subsidiary to (a) pay dividends or make any other distributions on such Subsidiary’s Equity Interests, (b) pay
65
any Indebtedness owed to the Company or any other Subsidiary of the Company, (c) make any loans or advances to the Company or any other Subsidiary of the Company or (d) transfer any of its property or assets to the Company or any other Subsidiary of the Company.
Section 10.12. Compliance with ERISA. The Company will not, and will not permit any of its Subsidiaries to:
(a) terminate any Plan subject to Title IV of ERISA so as to result in any material liability to the Company or any ERISA Affiliate;
(b) permit to exist any ERISA Event or any other event or condition, which would reasonably be expected to have a Material Adverse Effect;
(c) make a complete or partial withdrawal (within the meaning of ERISA Section 4201) from any Multiemployer Plan so as to result in any material liability to the Company or any ERISA Affiliate;
(d) enter into any new Pension Plan or Multiemployer Plan or modify any existing Pension Plan so as to increase its obligations thereunder which would reasonably be expected to have a Material Adverse Effect; or
(e) permit the present value of all nonforfeitable accrued benefits under any Pension Plan subject to Title IV of ERISA (using the actuarial assumptions utilized by the PBGC upon termination of a Plan) materially to exceed the fair market value of Plan assets allocable to such benefits, all determined as of the most recent valuation date for each such Plan.
Section 10.13. Accounting Changes. The Company will not, and will not permit any of its Subsidiaries to, (a) make any material change in accounting treatment or reporting practices, except any material change required by GAAP and which is approved in writing by the Accountants, or (b) adopt or utilize any change in GAAP or the application thereof for purposes of determining compliance with the covenants contained in Sections 10 and 11 hereof or elsewhere herein except as permitted by Section 1.2(c).
Section 10.14. No Amendment of Organizational Documents or Certain Other Documents. The Company will not, and will not permit any of its Subsidiaries to, without the prior written consent of the Majority Purchasers, (a) make any material changes in its equity capital structure (including in the terms of its authorized or outstanding capital stock), (b) permit any amendment to, modification of or supplement to the Organizational Documents of the Company or any Subsidiary of the Company (including the filing of any certificate establishing, setting forth, amending, modifying or supplementing the designations, preferences or rights pertaining to or other terms of any class or series of capital stock of the Company or its Subsidiaries), or (c) permit any amendment to, modification of or supplement to any of the Special Documents.
66
Section 11. Financial Covenants. The Company covenants and agrees that so long as any of the Notes shall be outstanding:
Section 11.1. Capital Expenditures.
(a) The Company will not, and will not permit any of its Subsidiaries to, make or incur any Capital Expenditure or any contractual commitment with respect to any Capital Expenditure if, after giving effect thereto, the aggregate amount of all Capital Expenditures by the Company and its Subsidiaries in any fiscal year (commencing with the fiscal year ending on September 30, 2006) would exceed $400,000.
(b) No commitment for any new Capital Expenditures shall be made at any time when a Default or Event of Default shall have occurred and shall be continuing.
Section 11.2. Maintenance of Minimum Interest Coverage. With respect to each of the periods of four consecutive fiscal quarters ending on the respective dates set forth below, the ratio of (i) Consolidated EBITDA for such period to (ii) Consolidated Interest Expense for such period will not be less than the corresponding amount set forth opposite such date:
Section 11.3. Maintenance of Maximum Leverage Ratio. With respect to each of the periods of four consecutive fiscal quarters ending on the respective dates set forth below, the ratio of (i) Consolidated Total Indebtedness as of the last day of such period to (ii) the Consolidated EBITDA for such period will not be greater than the corresponding amount set forth opposite such date:
67
Section 11.4. Maintenance of Minimum Consolidated EBITDA. With respect to each of the periods of four consecutive fiscal quarters ending on the respective dates set forth below, the amount of Consolidated EBITDA for such period will not be less than the corresponding amount set forth opposite such date:
68
Section 11.5. Maintenance of Minimum Consolidated Revenues. With respect to each of the periods of four consecutive fiscal quarters ending on the respective dates set forth below, the amount of Consolidated Revenues for such period will not be less than the corresponding amount set forth opposite such date:
69
Section 11.6. Maintenance of Minimum Cash Amount. The aggregate amount of Cash on hand (net of any overdrafts on Deposit Accounts) of the Company and its Subsidiaries as of the close of business on the last day of any fiscal quarter (commencing with the fiscal quarter ending December 31, 2005) will not be less than $500,000.
Section 12. Events of Default.
Section 12.1. Events of Default; Remedies. If any of the following events (herein called “Events of Default”) shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or by operation of law or otherwise):
(a) the Company shall default in the due and punctual payment or prepayment of all or any part of the principal of, or prepayment charge (if any) on, any Note when and as the same shall become due and payable, whether at stated maturity, by acceleration, by notice of prepayment or otherwise;
(b) the Company shall default in the due and punctual payment or prepayment of any interest on any Note when and as such interest shall become due and payable;
(c) the Company shall default in the performance or observance of any of the covenants, agreements or conditions contained in Section 7(a), Section 7(b), Section 7(c), Section 7(d), Section 7(h), Section 7(i), Section 9.2(a), Section 9.2(c), Section 9.6, Section 9.7, Section 9.8, Section 10 and Section 11 of this Agreement;
70
(d) the Company or any of its Subsidiaries shall default in the performance or observance of any of the covenants, agreements or conditions contained in this Agreement or any of the other Note Documents (other than those referred to in any subsection of this Section 12.1 other than this subsection (d)), and such default shall continue for a period of 30 days;
(e) (i) the Company or any of its Subsidiaries shall fail to pay any principal of, or interest on, or any other amount payable in respect of Indebtedness of such Person that is outstanding in a principal amount of at least $500,000 in the aggregate (but excluding Indebtedness outstanding under the Notes) when the same becomes due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), and such failure shall continue after the applicable grace period, if any, specified in the agreement or instrument relating to such Indebtedness; or (ii) any other event shall occur or condition shall exist under any agreement or instrument relating to any such Indebtedness and shall continue after the applicable grace period, if any, specified in such agreement or instrument, if the effect of such event or condition is to permit the acceleration of the maturity of such Indebtedness (whether or not such acceleration occurs); or (iii) any such Indebtedness shall be declared to be due and payable or required to be prepaid (other than by a regularly scheduled required prepayment), redeemed, purchased or defeased, or an offer to prepay, redeem, purchase or defease such Indebtedness shall be required to be made, in each case prior to the stated maturity thereof;
(f) the Company or any of its Subsidiaries shall (i) voluntarily commence any proceeding or file any petition seeking relief under the Bankruptcy Code, or any other federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or the filing of any petition described in (g) below, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Company or any of its Subsidiaries, or for a substantial part of the property or assets of the Company or any of its Subsidiaries, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors, (vi) admit in writing its inability to pay its debts as they become due or (vii) take any action for the purpose of effecting any of the foregoing;
(g) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i) relief in respect of the Company or any of its Subsidiaries, or of a substantial part of the property or assets of the Company or any of its Subsidiaries, under the Bankruptcy Code, or any other federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Company or any of its Subsidiaries, or for a substantial part of the property or assets of the Company or any of its Subsidiaries, or (iii) the winding-up or liquidation of the Company or any of its Subsidiaries, and such proceeding or petition shall continue undismissed for 60 days, or an order or decree approving or ordering any of the foregoing shall be entered;
(h) final judgment for the payment of money shall be rendered by a court of competent jurisdiction against the Company or any of its Subsidiaries, and the Company or such Subsidiary, as the case may be, shall not discharge the same or provide for its discharge in
71
accordance with its terms, or procure a stay of execution thereof, within 30 days from the date of entry thereof and within said period of 30 days, or such longer period during which execution of such judgment shall have been stayed, appeal therefrom and cause the execution thereof to be stayed during such appeal, and such judgment together with all other such judgments shall exceed in the aggregate $250,000;
(i) any representation, warranty or statement made by or on behalf of the Company or any of its Subsidiaries or by or on behalf of any officer of the Company or any of its Subsidiaries in this Agreement or any other Note Document, or in any financial statement, certificate or other instrument or document now or hereafter delivered pursuant to or in connection with any provision of this Agreement or the other Note Documents, shall prove to be false or incorrect or breached in any material respect on the date as of which made;
(j) a Liquidity Event shall occur;
(k) (i) an ERISA Event shall occur with respect to a Pension Plan or a Multiemployer Plan which shall have resulted or could reasonably be expected to result in liability of the Company or any ERISA Affiliate under Title IV of ERISA to such Pension Plan or Multiemployer Plan or to the PBGC in an aggregate amount in excess of $500,000; (ii) the Company or any ERISA Affiliate shall fail to pay when due, after the expiration of any applicable grace period, any installment payment with respect to its Withdrawal Liabilities under a Multiemployer Plan, in an aggregate amount in excess of $500,000; or (iii) the aggregate amount of Unfunded Pension Liabilities among all Pension Plans at any time shall exceed $1,500,000;
(l) any provision of this Agreement or any other Note Document shall, for any reason, not be or shall cease to be in full force and effect, or not be, or be asserted in writing by the Company or any of its Subsidiaries not to be, valid, binding and enforceable against any Person purported to be bound by it;
(m) any of the Security Documents shall not give or shall cease to give the Collateral Agent the Liens and the rights, powers and privileges purported to be created thereby, including a valid, enforceable and perfected first priority security interest in, and Lien on, all of the Collateral subject thereto in favor of the Collateral Agent, superior and prior to the rights of all third Persons (subject to Permitted Liens);
(n) as of the first anniversary of the Closing Date, neither an Initial Public Offering shall have occurred nor shall the Registration Statement have been declared effective by the SEC; or
(o) any Material Adverse Effect shall occur;
Section 12.2. Suits for Enforcement; Remedies Against Collateral. If any Event of Default shall have occurred and be continuing, the Collateral Agent (upon the direction of the Majority Purchasers) may proceed to protect and enforce the rights of the Purchasers on their behalf, either by suit in equity or by action at law, or both, whether for the specific performance of any covenant or agreement contained in this Agreement or the other Note Documents or in aid of the exercise of any power granted in this Agreement or the other Note Documents, and may proceed to enforce the payment of all sums due upon the Notes or under this Agreement or any of the other Note Documents, and such further amounts as shall be sufficient to cover the costs and expenses of collection (including reasonable counsel fees and disbursements), or to enforce any other legal or equitable right of the Purchasers or the Collateral Agent. In addition, the Collateral Agent shall have all of the rights and remedies of a secured creditor under the applicable provisions of the Uniform Commercial Code, and all rights and remedies provided for in the Security Documents or at law or in equity or otherwise. All amounts so collected or received hereunder (after deduction of the costs and expenses of collection) shall be applied to the payment in whole or in part of the Obligations in accordance with the provisions of Section 3.4(b).
Section 12.3. Remedies Cumulative. No remedy conferred upon the Purchasers or the Collateral Agent in this Agreement or in any of the other Note Documents is intended to be exclusive of any other remedy and each and every such remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity or otherwise.
Section 12.4. Remedies Not Waived. No course of dealing between the Company and the Purchasers or the Collateral Agent, and no delay or failure in exercising any rights under this Agreement or any of the other Note Documents, shall operate as a waiver of any of the rights of the Purchasers or the Collateral Agent.
Section 13. Registration, Exchange, and Transfer of Notes. The Company will keep at its principal executive office a register, in which, subject to such reasonable regulations as it may prescribe, but at its expense (other than transfer taxes, if any), the Company will provide for the registration and transfer of Notes. Whenever any Note shall be surrendered either at the principal executive office of the Company, or at the place of payment named in the Note, for transfer or
exchange, accompanied (if so required by the Company) by a written instrument of transfer in form reasonably satisfactory to the Company duly executed by the holder thereof or by such holder’s attorney duly authorized in writing, the Company will execute and deliver in exchange therefor a new Note (or Notes) in such denominations as may be requested by such holder, of like tenor and in the same aggregate unpaid principal amount as the aggregate unpaid principal amount of the Note so surrendered. Any Note issued in exchange for any other Note or upon transfer thereof shall carry the rights to unpaid interest and interest to accrue which were carried by the Note so exchanged or transferred, and neither gain nor loss of interest shall result from any such transfer or exchange. Any transfer tax or governmental charge relating to such transaction shall be paid by the holder requesting the exchange. The Company and any of its agents may treat the Person in whose name any Note is registered as the owner of such Note for the purpose of receiving payment of the principal of, prepayment charge (if any) and interest and other amounts on such Note and for all other purposes whatsoever, whether or not such Note be overdue.
Section 14. Lost, Stolen, Damaged and Destroyed Notes. Upon request of any Purchaser, the Company will issue and deliver at its expense, in replacement of any Note lost, stolen, damaged or destroyed, upon surrender thereof, if mutilated, a new Note in the same aggregate unpaid principal amount, and otherwise of the same tenor, as the Note so lost, stolen, damaged or destroyed, duly executed by the Company. The Company may condition the replacement of a Note reported by such Purchaser as lost, stolen, damaged or destroyed, upon the receipt from such Purchaser of an indemnity reasonably satisfactory to the Company.
Section 15. Collateral Agent.
Section 15.1. Appointment and Authorization. Each Purchaser hereby irrevocably appoints and authorizes the Collateral Agent to enter into each of the Note Documents to which it is a party (other than this Agreement) on its behalf and to take such actions as the Collateral Agent on its behalf and to exercise such powers under the Note Documents as are delegated to the Collateral Agent by the terms thereof, together with all such powers as are reasonably incidental thereto. Subject to the terms of Section 16.1(a) and to the terms of the other Note Documents, the Collateral Agent is authorized and empowered to amend, modify, or waive any provisions of this Agreement or the other Note Documents on behalf of the Purchasers. The provisions of this Section 15 are solely for the benefit of the Collateral Agent and the Purchasers and neither the Company nor any of its Subsidiaries shall have any rights as a third party beneficiary of any of the provisions hereof. In performing its functions and duties under this Agreement, the Collateral Agent shall act solely as agent of the Purchasers and does not assume and shall not be deemed to have assumed any obligation toward or relationship of agency or trust with or for the Company or any of its Subsidiaries. The Collateral Agent may perform any of its duties hereunder, or under the Note Documents, by or through its agents or employees.
Section 15.2. The Collateral Agent and Affiliates. The Collateral Agent shall have the same rights and powers under the Note Documents as any other Purchaser and may exercise or refrain from exercising the same as though it were not the Collateral Agent, and the Collateral Agent and its Affiliates may lend money to, invest in and generally engage in any kind of
74
business with the Company and its Subsidiaries or any Affiliate thereof as if it were not the Collateral Agent hereunder.
Section 15.3. Action by the Collateral Agent. The duties of the Collateral Agent shall be mechanical and administrative in nature. The Collateral Agent shall not have by reason of this Agreement a fiduciary relationship in respect of any Purchaser. Nothing in this Agreement or any of the Note Documents is intended to or shall be construed to impose upon the Collateral Agent any obligations in respect of this Agreement or any of the Note Documents except as expressly set forth herein or therein.
Section 15.4. Consultation with Experts. The Collateral Agent may consult with legal counsel, independent public accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or experts.
Section 15.5. Liability of the Collateral Agent. Neither the Collateral Agent nor any of its directors, officers, agents or employees shall be liable to any Purchaser for any action taken or not taken by it in connection with the Note Documents, except that the Collateral Agent shall be liable to the extent of its own gross negligence or willful misconduct as determined by a final non-appealable judgment of a court of competent jurisdiction. Neither the Collateral Agent nor any of its directors, officers, agents or employees shall be responsible for or have any duty to ascertain, inquire into or verify (i) any statement, warranty or representation made in connection with any Note Document or any borrowing hereunder; (ii) the performance or observance of any of the covenants or agreements specified in any Note Document; (iii) the satisfaction of any condition specified in any Note Document, except receipt of items required to be delivered to the Collateral Agent; (iv) the validity, effectiveness, sufficiency or genuineness of any Note Document, any Lien purported to be created or perfected thereby or any other instrument or writing furnished in connection therewith; (v) the existence or non-existence of any Default or Event of Default; or (vi) the financial condition of the Company or any of its Subsidiaries. The Collateral Agent shall not incur any liability by acting in reliance upon any notice, consent, certificate, statement, or other writing (which may be a bank wire, telex, facsimile or electronic transmission or similar writing) believed by it to be genuine or to be signed by the proper party or parties. The Collateral Agent shall not be liable for any apportionment or distribution of payments made by it in good faith and if any such apportionment or distribution is subsequently determined to have been made in error the sole recourse of any Purchaser to whom payment was due but not made, shall be to recover from other Purchasers any payment in excess of the amount to which they are determined to be entitled (and such other Purchasers hereby agree to return to such Purchaser any such erroneous payments received by them).
Section 15.6. Indemnification. Each Purchaser shall, in accordance with the aggregate outstanding principal amount of the Notes held by it, indemnify the Collateral Agent (to the extent not reimbursed by the Company) against any cost, expense (including counsel fees and disbursements), claim, demand, action, loss or liability (except such as result from the Collateral Agent’s gross negligence or willful misconduct as determined by a final non-appealable judgment of a court of competent jurisdiction) that the Collateral Agent may suffer or incur in connection with any action taken or omitted by the Collateral Agent (solely in its role as Collateral Agent as
75
set forth herein) under this Agreement or the other Note Documents. If any indemnity furnished to the Collateral Agent for any purpose shall, in the reasonable opinion of the Collateral Agent, be insufficient or become materially impaired, the Collateral Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified against even if so directed by Majority Purchasers until such additional indemnity is furnished. The obligations of Purchasers under this Section 15.6 shall survive the payment in full of the Obligations and the termination of this Agreement.
Section 15.7. Right to Request and Act on Instructions. The Collateral Agent may at any time request instructions from the Purchasers with respect to any actions or approvals which by the terms of this Agreement or of any of the Note Documents the Collateral Agent is permitted or desires to take or to grant, and if such instructions are promptly requested, the Collateral Agent shall be absolutely entitled to refrain from taking any action or to withhold any approval and shall not be under any liability whatsoever to any Person for refraining from any action or withholding any approval under any of the Note Documents until it shall have received such instructions from the Majority Purchasers. Without limiting the foregoing, no Purchaser shall have any right of action whatsoever against the Collateral Agent as a result of the Collateral Agent acting or refraining from acting under this Agreement or any of the other Note Documents in accordance with the instructions of the Majority Purchasers and, notwithstanding the instructions of the Majority Purchasers, the Collateral Agent shall have no obligation to take any action if it believes, in good faith, that such action exposes the Collateral Agent to any liability for which it has not received satisfactory indemnification in accordance with the provisions of Section 15.6.
Section 15.8. Credit Decision. Each Purchaser acknowledges that it has, independently and without reliance upon the Collateral Agent or any other Purchaser, and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Purchaser also acknowledges that it will, independently and without reliance upon the Collateral Agent or any other Purchaser, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking any action under the Note Documents.
Section 15.9. Collateral Matters. The Purchasers irrevocably authorize the Collateral Agent, at its option and in its discretion, to release any Lien granted to or held by the Collateral Agent under any Security Document (i) upon the payment in full of all Obligations; or (ii) constituting property sold or disposed of as part of or in connection with any disposition permitted under any Note Document (it being understood and agreed that the Collateral Agent may conclusively rely without further inquiry on a certificate of a Responsible Officer as to the sale or other disposition of property being made in full compliance with the provisions of the Note Documents). Upon request by the Collateral Agent at any time, the Purchasers will confirm the Collateral Agent’s authority to release particular types or items of Collateral pursuant to this Section 15.9.
Section 15.10. Agency for Perfection. The Collateral Agent and each Purchaser hereby appoint each other Purchaser as agent for the purpose of perfecting the Collateral Agent’s security interest in assets which, in accordance with the Uniform Commercial Code in any applicable
76
jurisdiction, can be perfected by possession or control. Should any Purchaser (other than the Collateral Agent) obtain possession or control of any such assets, such Purchaser shall notify the Collateral Agent thereof, and, promptly upon the Collateral Agent’s request therefor, shall deliver such assets to the Collateral Agent or in accordance with the Collateral Agent’s instructions or transfer control to the Collateral Agent in accordance with the Collateral Agent’s instructions. Each Purchaser agrees that it will not have any right individually to enforce or seek to enforce any Security Document or to realize upon any Collateral for the Obligations unless instructed to do so by the Collateral Agent (or consented to by the Collateral Agent, as provided in Section 16.8), it being understood and agreed that such rights and remedies may be exercised only by the Collateral Agent.
Section 15.11. Notice of Default. The Collateral Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default except with respect to defaults in the payment of principal, interest and fees required to be paid to the Collateral Agent for the account of Purchasers, unless the Collateral Agent shall have received written notice from a Purchaser or the Company referring to this Agreement, describing such Default or Event of Default and stating that such notice is a “notice of default”. The Collateral Agent will notify each Purchaser of its receipt of any such notice. The Collateral Agent shall take such action with respect to such Default or Event of Default as may be requested by Majority Purchasers in accordance with the terms hereof. Unless and until the Collateral Agent has received any such request, the Collateral Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable or in the best interests of the Purchasers.
Section 15.12. Successor Collateral Agent. The Collateral Agent may at any time give notice of its resignation to the Purchasers and the Company. TICC shall resign as Collateral Agent in favor of Seaview if (a) TICC does not exercise the Exchange Option on or before the earlier of (i) ten (10) Business Days after the date on which TICC shall receive a license from the California Department of Corporations pursuant to the California Finance Lenders Law or (ii) May 3, 2006, and (b) at any time on or after such date, Seaview shall have acquired one or more Notes pursuant to this Agreement and TICC shall not then hold any Notes. Upon receipt of any such notice of resignation, except as set forth in the preceding sentence, the Majority Purchasers shall have the right, in consultation with the Company, to appoint a successor Collateral Agent. If no such successor shall have been so appointed by the Majority Purchasers and shall have accepted such appointment within thirty (30) days after the retiring Collateral Agent gives notice of its resignation, then the retiring Collateral Agent may on behalf of the Purchasers appoint a successor Collateral Agent; provided that if the Collateral Agent shall notify the Company and the Purchasers that no Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice from the Collateral Agent that no Person has accepted such appointment and, from and following delivery of such notice, (i) the retiring Collateral Agent shall be discharged from its duties and obligations hereunder and under the other Note Documents and (ii) all payments, communications and determinations provided to be made by, to or through the Collateral Agent shall instead be made by or to each Purchaser directly, until such time as the Majority Purchasers appoint a successor the Collateral Agent as provided for above in this paragraph. Upon the acceptance of a successor’s appointment as the Collateral Agent hereunder, such successor shall succeed to and become vested with all of the
77
rights, powers, privileges and duties of the retiring (or retired) Collateral Agent, and the retiring Collateral Agent shall be discharged from all of its duties and obligations hereunder and under the other Note Documents (if not already discharged therefrom as provided above in this paragraph). After the retiring Collateral Agent’s resignation hereunder and under the other Note Documents, the provisions of this Section 15 shall continue in effect for the benefit of such retiring Collateral Agent and its sub-agents in respect of any actions taken or omitted to be taken by any of them while the retiring Collateral Agent was acting or was continuing to act as the Collateral Agent.
Section 16. Miscellaneous.
Section 16.1. Amendment and Waiver.
(a) No provision of this Agreement or any other Note Document may be amended, waived or otherwise modified unless such amendment, waiver or other modification is in writing and is signed by the Company and the Majority Purchasers (or the Collateral Agent upon the direction of the Majority Purchasers); provided that no such amendment, waiver or other modification shall, unless signed by all of the Purchasers directly affected thereby, (i) reduce the principal of, or rate of interest on, any Note; (ii) postpone or waive the date fixed for any payment (other than a payment pursuant to Section 3.1) of principal of any Note, or of interest on any Note; (iii) change the definition of the term “Majority Purchasers” or the percentage of Purchasers which shall be required for the Purchasers to take any action hereunder, which change shall be deemed to directly affect all Purchasers; (iv) release all or substantially all of the Collateral (except in connection with the payment in full of all of the Obligations), which action shall be deemed to directly affect all Purchasers; (v) amend, waive or otherwise modify this Section 16.1(a) or the definitions of the terms used in this Section insofar as the definitions affect the substance of this Section, which amendment, waiver or other modification shall be deemed to directly affect all Purchasers; (vi) consent to the assignment, delegation or other transfer by the Company or any of its Subsidiaries of any of their rights and obligations under any Note Document, which consent shall be deemed to directly affect all Purchasers; or (vii) permit the Company and its Subsidiaries to incur additional Indebtedness not permitted to be incurred under Section 10.1 as in effect on the date hereof; provided, further, that no such amendment, waiver or other modification shall affect the rights or duties of the Collateral Agent unless signed by the Collateral Agent.
(b) No failure or delay by any Purchaser or the Collateral Agent in exercising any right, remedy, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and are not exclusive of any rights, remedies, powers and privileges provided by law.
Section 16.2. Expenses.
(a) The Company agrees, whether or not the transactions hereby contemplated shall be consummated, to pay and save the Purchasers and the Collateral Agent harmless against any
78
and all liability for the payment of all expenses arising in connection with this Agreement and the other Note Documents, including all expenses incurred in connection with (i) the reproduction of such agreements and instruments and all stamp and other similar taxes (together in each case with interest and penalties, if any) which may be payable in respect of the execution and delivery of such agreements or instruments or the issuance, delivery or acquisition by the Purchasers of any Note or other instrument pursuant to this Agreement, (ii) all fees, taxes and other charges incurred in connection with the filing or recording of any Security Documents and in connection with any Lien, tax and judgment searches, (iii) all costs incurred in connection with the issuance of the Mortgage Policies, if any, including appraisal, survey and other title costs, (iv) the fees and disbursements of Nixon Peabody LLP and of any special or local counsel (including Breslow & Walker, LLP) incurred in connection with the performance of due diligence in respect of the Company and its Subsidiaries, the preparation and negotiation of this Agreement and the other Note Documents, and the consummation of the transactions hereby and thereby contemplated, and (v) the expenses of the Purchasers and the Collateral Agent incurred in connection with its investigation of the business, assets and financial condition of the Company and its Subsidiaries, including the fees and disbursements of any accountants or other experts retained by the Purchasers and the Collateral Agent for such purposes.
(b) The Company also agrees to pay to the Purchasers and the Collateral Agent on demand all expenses hereafter incurred by the Purchasers or the Collateral Agent (including reasonable counsel fees and disbursements) from time to time in connection with (i) the enforcement, attempted enforcement or preservation of any of the rights or remedies of the Purchasers or the Collateral Agent under this Agreement or any of the other Note Documents, (ii) any amendment or requested amendment of, or waiver or consent or requested waiver or consent under or with respect to, this Agreement or any of the other Note Documents, whether or not the same shall become effective, (iii) attendance by the Observer at meetings of the boards of directors (and committees thereof) of the Company and its Subsidiaries as permitted by Section 8.2, and (iv) the negotiation and documentation of any workout, restructuring or similar arrangement relating to the Company or its Subsidiaries.
(c) The Obligations of the Company under this Section 16.2 shall survive the payment or prepayment in full or transfer of any Note, the enforcement of any provision of this Agreement or the other Note Documents, any such amendments, waivers or consents, and any such workout, restructuring or similar arrangement.
Section 16.3. Survival of Representations and Warranties. All representations and warranties contained herein or made in writing by or on behalf of any party to this Agreement or otherwise in connection herewith shall (i) survive the execution and delivery of this Agreement and the delivery of the Notes to the Purchasers and shall continue in effect as long as any of the Notes is outstanding and thereafter as provided in Section 16.2 and Section 16.6, and (ii) be deemed to be material and to have been relied upon by the Purchasers and the Collateral Agent, regardless of any investigation made by the Purchasers or the Collateral Agent or on their behalf.
79
Section 16.4. Successors and Assigns; Assignment of Notes.
(a) This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns, provided that neither the Company nor any of its Subsidiaries may transfer or assign any of their respective rights or Obligations hereunder or under the other Note Documents without the prior written consent of the Majority Purchasers.
(b) Any Purchaser may at any time assign to one or more Eligible Assignees all or any portion of such Purchaser’s Notes, together with all related rights and obligations of such Purchaser hereunder. Except as the Collateral Agent may otherwise agree, the principal amount of the Notes so assigned shall be in a minimum aggregate amount equal to $100,000 or, if less, the aggregate unpaid principal amount of the Notes held by the assignor. The Company and the Collateral Agent shall be entitled to continue to deal solely and directly with such Purchaser in connection with the interests so assigned to an Eligible Assignee until the Collateral Agent shall have received and accepted an effective Assignment Agreement executed, delivered and fully completed by the applicable parties thereto.
(c) From and after the date on which the conditions described in Section 16.4(b) above have been met, (i) such Eligible Assignee shall be deemed automatically to have become a party hereto and, to the extent of the interests assigned to such Eligible Assignee pursuant to such Assignment Agreement, shall have the rights and obligations of a Purchaser hereunder and (ii) the assigning Purchaser, to the extent that rights and obligations hereunder have been assigned by it pursuant to such Assignment Agreement, shall be released from its rights (other than its indemnification rights) and obligations hereunder. Upon the request of the Eligible Assignee (and, as applicable, the assigning Purchaser) pursuant to an effective Assignment Agreement, the Company shall execute and deliver to Collateral Agent for delivery to the Eligible Assignee (and, as applicable, the assigning Purchaser) Notes in the aggregate principal amount of the Eligible Assignee’s Notes (and, as applicable, Notes in the principal amount of the Notes retained by the assigning Purchaser). Upon receipt by the assigning Purchaser of such Note, the assigning Purchaser shall return to the Company any prior Note held by it.
(d) Notwithstanding the foregoing provisions of this Section 16.4 or any other provision of this Agreement, any Purchaser may at any time pledge, and grant or assign a security interest in, all or any portion of the Notes held by it and its rights under this Agreement and the other Note Documents to secure obligations of such Purchaser, and in the event of any foreclosure of such pledge and security interest, the secured party thereof may sell and assign such Notes, together with such rights and interests of such Purchaser under this Agreement and the other Note Documents, in a public or private sale and may exercise all other rights of a secured party with respect thereto in accordance with the documentation governing such pledge and security interest and applicable law; provided that no such pledge or assignment shall release such Purchaser from any of its obligations hereunder or substitute any such pledgee or assignee for such Purchaser as a party hereto.
Section 16.5. Notices. All notices hereunder shall be in writing and shall be conclusively deemed to have been received and shall be effective (a) on the day on which delivered if delivered personally or transmitted by facsimile transmission, (b) one Business Day
80
after the date on which the same is delivered to a nationally recognized overnight courier service, (c) three Business Days after being sent by registered or certified United States mail, return receipt requested, or (d) if sent by e-mail as provided below, and shall be addressed:
(i) if to the Collateral Agent, to:
(ii) if to any Purchaser, to it at the address, facsimile number or e-mail address for such Purchaser set forth on Schedule I attached hereto or (as the case may be) on the Schedule attached to the Assignment Agreement whereby such Purchaser became a Purchaser hereunder;
(iii) if to the Company or any of its Subsidiaries, to:
Section 16.6. Indemnification. In consideration of the execution and delivery of this Agreement by the Purchasers and the Collateral Agent, the Company hereby agrees to defend, indemnify, exonerate and hold harmless each Purchaser, the Collateral Agent and each of the officers, directors, stockholders, members, managers, partners, Affiliates, trustees, employees and agents of each Purchaser and the Collateral Agent (herein collectively called the “Indemnitees”) from and against any and all liabilities, obligations, losses, damages, claims, actions, suits, proceedings, judgments, costs and expenses, including legal fees and other expenses incurred in the investigation, defense, appeal and settlement of claims, actions, suits and proceedings (herein collectively called the “Indemnified Liabilities”), incurred by the Indemnitees or any of them arising out of or resulting from any act or failure to act by the Company or any of its Subsidiaries or their respective officers, directors, employees, agents, representatives or Affiliates relating to:
(i) this Agreement, any of the other Note Documents, the issuance of the Notes or the transactions contemplated hereby or thereby, or the performance by the Company of its Obligations hereunder or thereunder, or
(ii) any Environmental Matter, any Environmental Law or the actual or alleged existence or release of any Hazardous Material,
Section 16.7. Confidentiality. (a) Each Purchaser and the Collateral Agent shall maintain in confidence in accordance with its customary procedures for handling confidential information and not disclose to any Person, all written information clearly marked “Confidential” that the Company or any of its Subsidiaries, or any of their authorized representatives, furnishes to such Purchaser or the Collateral Agent (as the case may be) on a confidential basis (“Confidential Information”), other than any such Confidential Information that becomes generally available to the public other than as a result of a breach by any Purchaser or the Collateral Agent of its obligations hereunder or that is or becomes available to such Purchaser or the Collateral Agent from a source other than the Company or any of its Subsidiaries, or any of
82
their authorized representatives, and that is not, to the actual knowledge of the recipient thereof, subject to obligations of confidentiality with respect thereto; provided, however, that each of the Purchasers and the Collateral Agent shall in any event have the right to deliver copies of any such documents, and to disclose any such information, to:
(i) its directors, officers, trustees, partners, employees, agents and attorneys;
(ii) its Affiliates, accountants, investment advisers, other professional consultants and rating agencies, and the directors, officers, trustees, partners, employees, agents and attorneys of each of the foregoing;
(iii) any Person to which any Purchaser offers to sell or pledge, or sells or pledges, any Note or any part thereof or interest or participation therein, and any other Person which offers to provide or is providing financing to such Purchaser; provided such Person agrees to keep such information confidential on terms similar to those set forth in this Section 16.7;
(iv) the SEC and any other federal or state regulatory authority or examiner which regulates or has jurisdiction over such Purchaser; and
(v) any other Person to which such delivery or disclosure may be necessary or appropriate (A) in compliance with any applicable law, rule, regulation or order, (B) in response to any subpoena or other legal process or informal investigative demand, (C) in connection with any litigation to which the Purchaser is a party, or (D) in connection with the enforcement of the rights and remedies of the Purchaser under this Agreement and the other Note Documents at any time when an Event of Default shall have occurred and be continuing (with respect to clauses (A), (B) and (C) of this subparagraph (v), in each case upon prior written notice to the Company to the extent reasonably practicable and not prohibited by law or court order, so that the Company may, at its sole cost and expense, contest such disclosure or seek confidential treatment thereof).
(b) Notwithstanding any other provision contained herein, each Purchaser shall have the right to issue a press release or other public statement, in form and substance as shall be determined by such Purchaser in its sole discretion, with respect to the transactions contemplated by this Agreement and the Note Documents. Each Purchaser shall also have the right to list the Company as a portfolio company of such Purchaser on the web site or sites owned and maintained by such Purchaser and in any other marketing materials as such Purchaser, in its sole discretion, shall determine.
Section 16.8. Setoff. During the continuance of any Event of Default, each Purchaser is hereby authorized by the Company at any time or from time to time, with reasonably prompt subsequent notice to the Company (any prior or contemporaneous notice being hereby expressly waived) to set off and to appropriate and to apply any and all (a) balances held by such Purchaser at any of its offices for the account of the Company or any of its Subsidiaries (regardless of whether such balances are then due to the Company or its Subsidiaries), and (b) other property at any time held or owing by such Purchaser to or for the credit or for the account of the Company
83
or any of its Subsidiaries, against and on account of any of the Obligations; except that no Purchaser shall exercise any such right without the prior written consent of the Collateral Agent. Any Purchaser exercising a right to setoff shall purchase for cash (and the other Purchasers shall sell) interests in each of such other Purchaser’s Pro Rata Share of the Obligations as would be necessary to cause all of the Purchasers to share the amount so set off with each other Purchaser in accordance with their respective Pro Rata Share of the Obligations. For such purposes, the “Pro Rata Share” of any Purchaser is equal to the ratio which the aggregate unpaid principal amount of the Notes at the time held by such Purchaser bears to the aggregate unpaid principal amount of all Notes at the time outstanding. The Company agrees, to the fullest extent permitted by law, that any Purchaser may exercise its right to set off with respect to the Obligations as provided in this Section 16.8.
Section 16.9. Usury Limitations. It is the intention of the Company and the Purchasers to conform strictly to applicable usury laws. Accordingly, notwithstanding anything to the contrary in this Agreement or the Notes, amounts constituting interest under applicable law and contracted for, chargeable or receivable hereunder or under the Notes shall under no circumstances, together with any other interest, late charges or other amounts which may be interpreted to be interest contracted for, chargeable or receivable hereunder or thereunder, exceed the maximum amount of interest permitted by law, and in the event any amounts were to exceed the maximum amount of interest permitted by law, such excess amounts shall be deemed a mistake and shall either be reduced immediately and automatically to the maximum amount permitted by law or, if required to comply with applicable law, be canceled automatically and, if theretofore paid, at the option of the Majority Purchasers, be refunded to the Company or credited on the principal amount of the Notes then outstanding.
Section 16.10. Punitive Damages. Each party to this Agreement agrees that it shall not have a remedy of punitive, special, exemplary, indirect or consequential damages against any other party to this Agreement in connection with any claim or dispute arising hereunder and hereby waives any right or claim to any such damages that such party now has or which may arise in the future in connection with any such claim or dispute, whether such claim or dispute is resolved by arbitration or judicially.
Section 16.11. Integration and Severability. This Agreement embodies the entire agreement and understanding among the Purchasers with regard to its subject matter, the Collateral Agent and the Company, and supersedes all prior agreements and understandings relating to the subject matter hereof. In case any one or more of the provisions contained in this Agreement or in any instrument contemplated hereby for such date, or any application thereof, shall be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein, and any other application thereof, shall not in any way be affected or impaired thereby.
Section 16.12. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall together constitute one and the same instrument. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic means shall be effective as delivery of a manually executed counterpart of this Agreement. Delivery of manually executed counterparts of this
84
Agreement shall immediately follow delivery by telecopy or other electronic means, but the failure to so deliver a manually executed counterpart shall not affect the validity, enforceability, or binding effect hereof.
Section 16.13. Contingent Payment.
(a) Subject to the provisions of Section 16.13(f), if, as of the Maturity Date, the Total Rate of Return (as defined below) with respect to any Purchaser, determined without taking into account any payment or issuance of shares of Company Common Stock made pursuant to the provisions of this Section 16.13(a), shall be less than 15.0% per annum, then on the Payment Date (as defined below) the Company shall pay to such Purchaser, in addition to all other amounts payable under this Agreement, the Notes and the other Note Documents, an amount (each a “Make-Whole Amount”) such that, if such amount had been paid to such Purchaser on the Maturity Date and had been taken into account in determining the Total Rate of Return as of such date, would have resulted in a Total Rate of Return of 15.0%; provided that in the event the Company elects to pay the Make-Whole Amount in the form of shares of Company Common Stock, the aggregate number of such shares issued by the Company to all Purchasers pursuant to this Section shall not in any event exceed 1,167,000 (as adjusted to take account of any stock dividends, stock splits or similar events affecting the Company Common Stock occurring after the date hereof), and, if by reason of such limitation the aggregate number of such shares to be distributed to the Purchasers shall be less than the aggregate number that would have been so distributed in the absence of such limitation, then such shares shall be distributed to the Purchasers pro rata according to the respective Make-Whole Amounts that such Purchasers are entitled to receive pursuant to this Section. Each Make-Whole Amount shall be paid in cash or, at the option of the Company, in shares of Company Common Stock valued at the Market Price (as defined below) thereof as of the Maturity Date.
(b) For the purposes hereof, the “Total Rate of Return” shall be equal to the internal rate of return per annum realized or deemed realized by the Purchasers (taken together and treated as a single investor) on their investment in the Company represented by the Preferred Shares, the Warrants and the Notes issued by the Company pursuant to this Agreement and the Stock Purchase Agreement and the shares of Company Common Stock received by the Purchasers upon exercise of the Warrants or otherwise pursuant to the provisions of this Agreement (the “Combined Investment”), and shall be computed on the basis of the following:
(i) except as otherwise provided in Section 16.13(b)(ii), the computation of the Total Rate of Return shall be made for the period from and including the Closing Date (in the case of TICC or any successor thereto) or the date of Seaview’s initial cash investment in the Preferred Shares or the Notes (in the case of Seaview or any successor thereto) to and including the Maturity Date;
(ii) the following assumptions shall be made in computing the Total Rate of Return: (A) in the event that on the Maturity Date any Purchaser shall hold any Warrants or any shares of Company Common Stock issued upon the exercise of Warrants, the computation shall be made based on the assumption that all such Warrants were exercised on the Maturity Date and all shares of Company Common Stock received by the
85
Purchasers upon such exercise and any other shares of Company Common Stock previously received by the Purchasers upon the exercise of Warrants were sold by them on the Maturity Date for a price per share in cash equal to the Market Price as of such date (whether or not such Warrants are actually exercised or such shares of Company Common Stock are actually sold on such date); and (B) solely for purposes of computing the Total Rate of Return after giving effect to any Make-Whole Amount payable pursuant to Section 16.13(a), any cash amount paid pursuant thereto shall be deemed to have been paid on the Maturity Date, and any shares of Company Common Stock issued pursuant thereto shall be deemed to have been issued on the Maturity Date and to have been sold by the Purchasers on the Maturity Date for a price per share in cash equal to the Market Price as of such date; and
(iii) the computation shall take into account (A) all cash payments made by each Purchaser in respect of its Combined Investment during the applicable period referred to in paragraph (i) above, including, without limitation, the payment of the purchase price for the Preferred Shares issued on the Closing Date (or, in the case of Seaview or any successor thereto, payment of the purchase price for the Preferred Shares or Notes purchased by it on such later date as such purchase is effected), payment of the exercise price of any Warrants exercised or assumed to have been exercised in accordance with the provisions of the foregoing paragraph (ii), and all out-of-pocket costs and expenses paid by each Purchaser in connection with the Combined Investment for which the Company is responsible but which have not been reimbursed to such Purchaser; and (B) all dividends received by the respective Purchasers in respect of the Preferred Shares, all payments of principal, interest and prepayment charges (if any) received by the Purchasers in respect of the Notes or pursuant to the terms of this Agreement during the period from and including the Closing Date to and including the Maturity Date, and any payment received (or assumed to have been received pursuant to the provisions of paragraph (ii) above) in respect of any sale of shares of Company Common Stock made on or prior to the Maturity Date (or assumed to have been made on the Maturity Date pursuant to paragraph (ii) above), but shall exclude interest at the Post-Default Rate (to the extent such interest exceeds in amount the interest that would have been payable in the absence of an Event of Default) and any fees or other amounts paid in connection with the waiver of any Event of Default or in connection with any amendment, workout or restructuring of the Note Documents or the Indebtedness incurred pursuant thereto.
(c) As used herein, the term “Market Price” shall mean, as of any date of determination, with respect to the Company Common Stock, (A) if the Company Common Stock is listed or admitted to trading on any national securities exchange, the average of the last reported sale prices, regular way, per share of Company Common Stock for each of the 20 consecutive trading days preceding such day on the principal national securities exchange on which the shares of Company Common Stock is listed or admitted to trading (without taking into account any extended or after-hours trading session), or (B) if the Company Common Stock is not listed or admitted to trading on any national securities exchange but is listed on Nasdaq or quoted in the OTC Bulletin Board, the average of the last reported sale prices (or, if last-sale price quotations are not available, the average of the last available bid and asked prices) per share
86
of Company Common Stock for each of the days in such 20 trading day period as reported on Nasdaq or the OTC Bulletin Board (without taking into account any extended or after-hours trading session), or (C) if the Company Common Stock is traded in the over-the-counter market but not quoted on the OTC Bulletin Board, the average of the last available bid and asked prices per share of the Company Common Stock for each of the days in such 20 trading day period as quoted in the Pink Sheets Electronic Quotation Service or, if not so quoted, as furnished by any member of the NASD selected by the Company, or (D) if the Company Common Stock is not publicly traded, the Market Price for such day shall be the fair market value per share thereof as determined jointly by the Company and the Collateral Agent.
(d) Within 30 days after the Maturity Date, the Collateral Agent shall give written notice to the Company and each Purchaser (the “Make-Whole Notice”) with respect to the amount of the Make-Whole Amount (if any) to be paid to each Purchaser, which notice shall contain a calculation thereof in reasonable detail, including the Market Price per share of the Company Common Stock determined by the Collateral Agent for such purpose. If the Company disagrees with the amount of the Market Price specified in the Make-Whole Notice or disagrees for any other reason with the calculation of the Make-Whole Amount therein stated, it shall so notify the Collateral Agent in writing within five (5) Business Days after receipt of the Make-Whole Notice, stating the bases for its objection thereto (the “Objection Notice”). If a Notice of Objection is not received by the Collateral Agent within period of five (5) Business Days, the Make-Whole Amount as determined by the Collateral Agent in the Make-Whole Notice shall be final and binding for all purposes of this Section 16.13. If a Notice of Objection is received by the Collateral Agent on a timely basis and the parties are unable to reach agreement with respect to the matters set forth therein within a period of 15 days after such receipt, the Make-Whole Amount (including the relevant Market Price) shall be determined in good faith by an independent investment banking firm selected jointly by the Company and the Collateral Agent or, if that selection cannot be made within 15 days, by an independent investment banking firm selected by the American Arbitration Association in accordance with its rules. The fees and expenses of such independent investment banking firm shall be borne equally by the Company and the Collateral Agent. For the purposes hereof, the determination of the “fair market value” of any shares of Company Common Stock shall be based upon the market value of the Company determined on a going concern basis, assuming that all of the outstanding shares of Company Common Stock are being sold as between a willing buyer and a willing seller in an arm’s length transaction for cash payable in full on completion, and taking into account all prior or preferential rights and conversion rights of holders of Company Preferred Stock at the time outstanding and any shares of any class which may be issuable under any then outstanding options, warrants or other rights to subscribe for, or securities convertible into or exchangeable for, shares of Company Common Stock, and taking into account all other relevant factors determinative of value, provided that no discount shall be imposed by reason of such shares of Company Common Stock constituting a minority ownership interest or by reason of the illiquidity of such shares or any contractual or other restrictions on the sale or transfer thereof. The determination of such investment banking firm with respect to the matters submitted to it hereunder shall be final and binding on all parties hereto.
(e) The Company shall pay the applicable Make-Whole Amount (if any) to each Purchaser within ten (10) Business Days after receipt of the Make-Whole Notice, or, if a timely
87
Notice of Objection shall be received by the Collateral Agent as provided in paragraph (d) above, within ten (10) Business Days after all disputes with respect to the matters set forth therein shall be finally resolved in accordance with the provisions hereof.
(f) Notwithstanding the foregoing provisions of this Section 16.13, no Make-Whole Amount shall be payable to any Purchaser if (i) the Company completes a Qualified IPO at any time which is more than 545 days prior to the Maturity Date, (ii) during any period of 180 consecutive days commencing on or after the first anniversary of the effective date of such Qualified IPO and ending prior to the Maturity Date, the arithmetic mean of the VWAPs for each of the trading days in such period shall be $6.00 or more (as adjusted to take account of any stock dividends, stock splits or similar events affecting the Company Common Stock occurring after the date hereof), and (iii) at all times during such period of 180 consecutive days, the Company Common Stock shall be listed on a United States national securities exchange or on the Nasdaq National Market.
Section 16.14. Governing Law. THIS AGREEMENT AND THE NOTES SHALL BE CONSTRUED IN ACCORDANCE WITH AND SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.
Section 16.15. Submission to Jurisdiction; Waiver of Service and Venue.
(a) THE COMPANY CONSENTS AND AGREES TO THE NON-EXCLUSIVE JURISDICTION OF ANY STATE OR FEDERAL COURT SITTING IN THE COUNTY OF NEW YORK, STATE OF NEW YORK, AND WAIVES ANY OBJECTION BASED ON VENUE OR FORUM NON CONVENIENS WITH RESPECT TO ANY ACTION INSTITUTED THEREIN.
(b) THE COMPANY HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS UPON IT AND CONSENTS THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE BY HAND DELIVERY OR BY REGISTERED OR CERTIFIED UNITED STATES MAIL TO THE COMPANY AT ITS ADDRESS SET FORTH IN SECTION 16.5.
(c) NOTHING IN THIS SECTION 16.15 SHALL AFFECT THE RIGHT OF THE PURCHASERS OR THE COLLATERAL AGENT TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR AFFECT THE RIGHT OF THE PURCHASERS OR THE COLLATERAL AGENT TO BRING ANY ACTION OR PROCEEDING AGAINST THE COMPANY OR ITS PROPERTY IN THE COURTS OF ANY OTHER JURISDICTION.
Section 16.16. Waiver of Right to Trial by Jury. EACH OF THE COMPANY, THE PURCHASERS AND THE COLLATERAL AGENT HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (i) ARISING UNDER THIS AGREEMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR (ii) IN ANY WAY CONNECTED WITH OR RELATED OR
88
INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM IN RESPECT TO THIS AGREEMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE. THE COMPANY, THE PURCHASERS AND THE COLLATERAL AGENT HEREBY AGREE AND CONSENT THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT ANY PARTY MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.
Contents
Share
More